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Abstract
The goal of this research is to investigate the role of K32 and K33 in the catalytic
mechanism of R67 dihydrofolate reductase (DHFR). K32 is located in the active site
pore and is the only charged residue in the active site while K33 is located on the surface
of R67 DHFR. Both of the ligands for R67 DHFR, NADPH and dihydrofolate (DHF),
have negative charges capable of forming ionic interactions with symmetry related K32
residues. NMR, DELPHI, and docking studies predict that K32 is involved in ionic
interactions with the 2’phosphate of NADPH. Docking studies also predict that K32
participates in ionic interactions with DHF. Mutagenesis of K32 in the R67 DHFR
homotetramer results in the formation of an inactive dimer. Thus, the role of K32 cannot
directly be tested. Therefore, the role of ionic interactions in ligand binding and catalysis
was experimentally examined using salt effects on Kd1 (NADPH), total heat of binding for
folate (qTotal), Km (NADPH), Km (DHF), kcat, kcat/Km (NADPH), and kcat/Km (DHF). Salt sensitivities
of these parameters indicate that ionic interactions are involved in binding both cofactor
and substrate. To examine the number of ionic contacts with each ligand, slopes of loglog plots of various binding and kinetic parameters vs. ionic strength can be used.
However, one of the requirements that must be met for the slope to be directly
proportional to the number of ionic contacts involved in binding and catalysis is that
different anions produce the same effect on the slopes of these plots. Specific anion
effects occur with R67 DHFR when salt sensitivities are compared in the presence of
NaCl, NaF, or NaSCN. This makes quantation of the number of ionic contacts between
R67 DHFR and each ligand difficult. In order to test the involvement of the 2’phosphate
moiety of NADPH in ionic contacts, steady-state kinetics were performed using the
iv

alternate cofactor NADH. Significant effects were observed on kcat/Km (NADH) compared
to kcat/Km (NADPH) revealing the 2' phosphate is most likely involved in an ionic interaction
with R67 DHFR.
Direct analysis of the role of K32 in binding and catalysis was examined using a
quadruplicated gene construct of R67 DHFR containing one to two asymmetric K32M
mutations. One K32 mutation in each half pore of the enzyme results in a decrease in kcat
but has minimal effects on Km values. On the other hand, two K32 mutations in the same
half pore result in significant effects on the Km values for NADPH and DHF as well as an
enhancement of kcat. The decrease in kcat observed with the K32M double asymmetric
mutants that possess a single K32M substitution in each half-pore support that R67
DHFR uses its symmetry to facilitate catalysis. This may arise from increasing the
number of species available to form the transition state.
The increase in Km (NADPH) and Km (DHF) as well as the increase in kcat observed with
the K32M mutant that possesses two substitutions in the same half pore supports that an
ionic interaction(s) is lost to reach the transition state. This mutant possesses 2 K32M
substitutions in the same half pore (in the predicted binding site for DHF), resulting in a
decrease in the affinity for DHF and NADPH in the ground state. These data suggest that
K32 is involved in ionic contacts with DHF in the ground state. The unexpected
elevation in Km (NADPH) however, may not reflect the true Kd (NADPH) for this mutant.
Formation of the transition state is facilitated with this mutant. One possible scenario
consistent with an increase in kcat when two K32 residues are substituted in the same half
pore involves the movement of DHF into a position that facilitates better overlap between
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the nicotinamide ring of NADPH and the pteridine ring of DHF thus facilitating the
chemistry.
The salt sensitivities of the various binding and kinetic parameters, the large
effects on kcat/Km in the presence of the alternate cofactor NADH, and the effects of the
K32M double asymmetric mutants, reveal that K32 is most likely involved in at least one
ionic contact with NADPH, and at least one ionic contact with DHF in the ground state.
To allow formation of the transition state, one of these ionic interactions is lost.
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Part I: Introduction to R67 Dihydrofolate Reductase, a Functional and
Structural Overview

1

General Introduction to Dihydrofolate Reductases
Dihydrofolate reductases (DHFRs) are ubiquitous enzymes that catalyze the
NADPH dependent reduction of dihydrofolate (DHF) to tetrahydrofolate (THF). THF is
essential for the formation of thymidine, a precursor of the purine base thymine, purine
nucleosides, methionine, and other metabolites (1). Thus, inhibition of DHFRs impairs
both DNA and protein synthesis consequently resulting in cell death. Due to their role in
cell survival, these enzymes have been drug targets. One clinically effective inhibitor of
bacteria chromosomal DHFRs is the antibiotic trimethoprim (TMP). However, Rplasmid encoded DHFRs have been discovered to confer resistance to this antibiotic (2).
R-plasmid Dihydrofolate Reductases
To date, twelve groups of R-plasmid DHFRs have been discovered, namely types
I-XII (2). However, the type II R-plasmid encoded DHFRs confer the strongest
resistance to TMP. There are three type II R-plasmid DHFRs: R67, R388, and R751 (35). These R-plasmid DHFRs share greater than 78% amino acid sequence identity with
differences occurring mainly at the amino terminus of these proteins (6). However,
removal of the first 17 amino acids in the amino terminus does not impair the activity of
R67 DHFR, indicating they are not necessary for function (7).
R67 DHFR is fascinating as it is structurally and genetically divergent from other
known DHFRs (6, 8). One possibility is R67 DHFR arose from an NADP-linked oxidoreductase. It is often compared to the chromosomal enzyme produced in E.coli, as it
allows host E.coli to sustain life when the chromosomally encoded DHFR is inhibited.
Although the chromosomally encoded enzyme is susceptible to inhibition at
concentrations of trimethoprim around 1nm, R67 DHFR remains fully active. In
2

addition, this enzyme is only weakly inhibited by methotrexate, which severely inhibits
chromosomal DHFR (8, 9). This indicates there must be significant differences in the
structure as well as in the binding and catalytic properties of the R-plasmid encoded
enzyme and the chromosomally encoded DHFR enzyme.
Comparison of the Structures of R67 DHFR and E.coli Chromosomal DHFR
Structure of R67 DHFR
R67 DHFR was first crystallized as a dimer (9); however, more recent
crystallographic data (10), in combination with sedimentation equilibrium and molecular
sieving studies (3, 11), reveal that this enzyme functions in vivo as a tetramer (12). In
1995, the tetramer crystal structure was solved to 1.7 Å resolution after chymotrypsin
cleavage of the first 17 amino acids. This structure reveals that each monomer consists of
five antiparallel β–strands (labeled A-E) connected by short loops and a single 3-10 helix
(10) (Figure 1). Monomer 1 is made up of residues 1-78, monomer 2 by residues 101178, monomer 3 by residues 201-278, and monomer 4 by residues 301-378.
The monomer-monomer interfaces of R67 DHFR are stabilized by an intersubunit
β-barrel formed by the association of β-strands B, C, and D in adjacent subunits.
Hydrophobic packing of sidechains within the intersubunit β-barrel, hydrogen bonding of
anti-parallel β-sheets in symmetry related strands, and van der Waals interactions
between methionine 26 (M26) residues in adjacent monomers also stabilize the
monomer-monomer interfaces (10).
The dimer-dimer interface of R67 DHFR is also stabilized by several bonding
interactions. These stabilizing forces include: tryptophan 38 (W38), 138, 238, and 338
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Figure 1. The α-carbon backbone of R67 DHFR. R67 DHFR is a homotetramer with a
single active site pore. Each monomer is folded into 5 antiparallel β-sheets and a 310
helix. Monomer A is in green, monomer B is blue, monomer C is violet, and monomer D
is purple. The dimer-dimer interface is stabilized by hydrogen bonding between H62
(red) and S59 (from a second subunit) as well as H62 imidazole stacking interactions
between symmetry related partners (11, 13). The mouth of the pore is 24 Å X 12 Å with
a reduced diameter in the center of the pore. This is due to an hourglass shape arising
from symmetry related Q67 residues (yellow) which form the “floor and ceiling” of the
active site creating an hourglass shaped pore (10).
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stacking interactions; hydrogen bonding between glutamine 67 (Q67) residues in adjacent
subunits; loop-loop interactions between residues in the loop connecting β-strands C and
D (residues 60-65) and the four residues preceding strand B; hydrophobic stacking
interactions between the imidazole ring of histidine 62 (H62) residues in symmetry
related monomers; and, hydrogen bonding between the Nε2 of histidine 62 (H62) in one
monomer and the γ-OH of serine 59 (S59) in a symmetry related adjacent monomer (10,
11). While all of these interactions are important for the stabilization of the dimer-dimer
interface, pH titration and NMR chemical shift data demonstrate that the tetramer to twodimer equilibrium is pH dependent and that protonation of H62 results in the observed
dissociation of the tetramer into two dimers (11).
Crystallographic data also reveals that R67 DHFR possesses a single active site
pore with 222 symmetry. Residues from each of its four identical subunits make up the
pore, including lysine 32 (K32), alanine 36 (A36), tyrosine 46 (Y46), threonine 51 (T51),
glycine 64 (G64), serine 65 (S65), valine 66 (V66), glutamine 67 (Q67), isoleucine 68
(I68), and tyrosine 69 (Y69) (10) (Figure 2). S65, V66, Q67, I68, and Y69 make up 47%
of the surface area of the active site (14). The dimensions of the active site pore are 25 Å
in length and 18 Å in width. A total of 28 ordered water molecules are located in the
pore, which has the shape of an “hourglass” (10). This shape arises from symmetry
related Q67 residues that create the “floor and ceiling” of the active site, producing a
diameter in the center of the pore almost half the width at the mouth (10) (Figure 1).
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Figure 2. CPK surface of R67 DHFR illustrating residues lining the active site. K32 is
shown in yellow, Y46 is purple, S65 is orange, Q67 is lavender, I68 is blue, and Y69 is
green (10, 14).

6

Structure of E.coli Chromosomal DHFR
Numerous crystallographic and NMR studies have been performed which
illustrate that chromosomal DHFR is a monomeric protein with a molecular weight of
18,000 daltons. The structure of this monomer consists of 8 β-sheets connected by 4 αhelices (15-17). This enzyme possesses a single active site that contains a specific
binding pocket for NADPH formed by β strands B (38-44) and E (90-95), and α-helices
C (44-50) and F (97-104) as well as a hydrophobic binding site for DHF (L54, I50, and
F31) with the exception of a single polar residue, aspartate 27 (D27). Following cofactor
and substrate binding, a conformational change occurs in the Met-20 loop (residues 924), which connects the βA strand to the αB strand. Residues 16-19 in this loop go from
being disordered in the holoenzyme to a type I β-turn. Ordering of this region of the
Met-20 loop results in the “closed conformation” of the active site, thus solvent is
excluded to create a hydrophobic environment for catalysis (18).
Properties of NADPH and DHF
Commonly, the same ligands can be used for many different reactions that take
place in the cell. NADPH is an example of this, serving as a cofactor in many
biosynthetic reactions. It possesses a net charge of –3, arising from 2 regions of negative
charge, a phosphate group at the 2’ position off the hydroxyl group of AMP and the
pyrophosphate moiety linking the ribose of AMP to the ribose attached to the reactive
part of the molecule, the nicotinamide ring (Figure 3). The nicotinamide ring contains
two reactive hydrogens on C4, a pro-R hydrogen below the plane of the ring and a pro-S
hydrogen that is above the plane of the ring which participate in NADPH dependent
hydride transfer reactions. R67 DHFR transfers the pro-R hydrogen of NADPH.
7

A

B

C

D

Figure 3. Illustrations of ligands that bind in the active site pore of R67 DHFR. (A)
DHF is similar in structure to folate (depicted above) with the exception of a single bond
between C7 and N8 in the pteridine ring. DHF has a net negative charge of –2. (B)
NADPH has a net negative charge of –3. (C) Congo Red dye and (D) novabiocin
effectively inhibit R67 DHFR activity (Ki = 2µM and 60µM) (unpublished results).
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In addition, most enzymes can only use the β–epimer of NADPH for catalysis.
Interestingly, R67 DHFR can use either the α or β-epimer of NADPH for catalysis.
Although, the catalytic rate of R67 DHFR is higher in the presence of the β–epimer of
NADPH. This ability to utilize either epimer is uncommon (19).
DHF is present in the cell in a polyglutamylated form to prevent its passage
through the membrane to the outside of the cell. The monoglutamylated form of DHF is
used for in vitro studies and is fully active, as it possesses the reactive pteridine ring.
This molecule possesses a net charge of –2, which arises from the negatively charged
carboxyl groups on the glutamate residue that forms the tail of DHF (Figure 3).
Numerous studies indicate that before hydride transfer occurs DHF must be protonated at
the N5 position to allow the C6 of the pteridine ring to accept the hydride from NADPH.
Consistent with this finding, both Raman spectroscopy and H62C mutant studies indicate
that R67 DHFR requires protonation of the N5 of DHF to facilitate catalysis (20, 21).
Binding Mechanism for NADPH and DHF in the Active Site Pore of R67 DHFR
Another unique feature of this enzyme is its binding mechanism. Fitting of the
electron density associated with bound folate is consistent with 2 folate molecules
binding per tetramer, even though there are four potential binding sites (10). However,
the actual number of binding sites available is dictated by ligand cooperativity. This is
illustrated by isothermal titration calorimetry (ITC) and fluorescence anisotropy studies,
which indicate that 2 NADPH, 2 DHF, or 1NADPH and 1 DHF molecule can bind in the
active site pore of R67 DHFR (22). The latter forms the productive ternary complex.
NADPH displays negative cooperativity between the first and second binding events with
macroscopic Kds of 2.5 and 95 µM. The negative cooperativity most likely results from
9

steric repulsion. Binding between DHF molecules is positively cooperative, Kd1=125 µM
and Kd2=8.8 µM (Figure 4). Further, a stoichiometry of 1 is observed upon titrating
folate into a 1:1 mixture of R67 DHFR:NADPH indicating 1 folate molecule binds to
form the ternary complex and displays positive cooperativity (22).
ITC, fluorescence anisotropy, and structural data indicate the active site pore of
R67 DHFR can only accommodate 2 ligands simultaneously (10, 22). To achieve
preferential formation of the active ternary complex, this enzyme uses various methods:
numerous non-covalent interactions to tightly bind NADPH, negative cooperativity
between 2 NADPH molecules, positive cooperativity between 2 DHF molecules, and
positive cooperativity between bound NADPH and DHF. Using this binding data, a
strategy may be devised that R67 DHFR uses to form the active ternary complex. The
enzyme utilizes the 222 symmetry of its active site pore to facilitate NADPH binding, as
it has four potential binding sites. NADPH binds near the center of the active site,
resulting in the loss of symmetry. This limits the number of sites and orientations
available for DHF binding and thereby facilitates formation of the active ternary
complex. This binding scenario arises from condensation of the various Kd values and
proposes NADPH binds first, followed by DHF, indicating that binding of ligands in the
active site pore of R67 DHFR does not follow a random addition pattern (22).
Inhibitor Binding to R67 DHFR
Another interesting aspect of R67 DHFR is how it is able to avoid enzymatic
inhibition by the folate analogs trimethoprim (TMP) and methotrexate (MTX), which
severely inhibit bacterial and vertebrate DHFRs (5). Comparison of crystal structures of
MTX and TMP bound to chromosomal DHFR to the crystal structure of R67
10

Figure 4. Binding scheme for R67 DHFR determined by ITC (22). This schematic
reveals that the ligands prefer to bind in a non-random fashion where NADPH binding
occurs first in the active site pore followed by DHF. Formation of non-productive
complexes leads to inhibition of enzyme activity as observed in various mutants (14, 20,
23).
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DHFR•folate lends insight into how R67 DHFR avoids inhibition (10, 18). Both of these
compounds contain an amino group substitution at the C4 of the pteridine ring (MTX) or
the pyrimidine ring (TMP). Crystallography data has shown that these compounds bind
very tightly to the chromosomal enzyme because its active site is such that it allows the
formation of hydrogen bonds between backbone carbonyl oxygens of A97 and L4 and the
amino group located at C4 of MTX and TMP (18). In addition, the amino group
substituent at C4 favors protonation at N1 in the pteridine ring of MTX and the
pyrimidine ring of TMP. This proton at N1 is involved in a hydrogen bond with a nearby
carboxylate group (D27) in the active site of the chromosomal enzyme. Conversely, the
backbone amide group of I68 in R67 DHFR appears positioned so that it causes steric
repulsion with the amine group at the C4 position on the pyrimidine ring of both TMP
and pteridine ring of MTX. Additionally, the active site of R67 DHFR lacks atoms in the
correct orientation to hydrogen bond with the amino group at C4 and a carboxyl group in
the correct orientation to interact with the proton at N1 in the pteridine ring of MTX and
the pyrimidine ring of TMP (10).
These results illustrate how R67 DHFR avoids inhibition by these clinical
compounds. A major question remains: what will inhibit the activity of this enzyme?
Kinetic studies with Congo Red dye and novobiocin illustrate these are effective
competitive inhibitors of R67 DHFR (unpublished results) (Figure 3). While these
compounds are not themselves useful in a clinical sense, they might be helpful in the
design of an inhibitor that possesses some of the structural characteristics of these
molecules. Currently, ITC and inhibition kinetics are being performed to identify the
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importance of the various moieties of DHF and NADPH, which could potentially be used
in the design of an effective inhibitor for R67 DHFR (Jackson, Ph.D. project).
Comparison of Catalytic Mechanism of R67 DHFR to E.coli Chromosomal DHFR
Proton Donor in Active Site
Previously conducted studies indicate the N5 of the pteridine ring of DHF must be
protonated before C6 can accept a hydride from NADPH (24-27). The solution pKa of
DHF is 2.59. E.coli DHFR elevates the pKa of DHF to ~6.5 (28). Thus, the increase in
the pKa of bound DHF by E.coli DHFR facilitates protonation of DHF. One model for
catalysis involves aspartate 27 (D27) serving as a catalytic acid by protonating the N5 of
the pteridine ring of DHF leading to high catalytic efficiency (24, 29, 30). Still debated is
the issue of whether D27 directly protonates the N5 of the pteridine ring of DHF or uses
an intermediary water (18, 24, 31).
In contrast, the pKa of DHF when in complex with R67 DHFR is less than 4,
consistent with no to minimal elevation of the pKa of DHF when in complex with R67
DHFR (21, 29, 32). The pH-rate profile of R67 DHFR is bell-shaped with a maximum
occurring around pH 6. This acidic pKa corresponds to a protein concentration dependent
loss of activity as the active tetramer dissociates into relatively inactive dimers (33). pH
profiles using the disulfide-linked tetramer H62C, to prevent dissociation of the tetramer,
indicates that there is a linear increase in kcat with decreasing pH. The increase in kcat
with decreasing pH suggests that the enzyme uses pre-protonated DHF as a substrate for
its hydride transfer reaction (33). The absence of an inflection point in the pH-rate profile
of this mutant, as well as structural data of the active site, indicate R67 DHFR lacks a
proton donor in the active site.
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Raman difference spectroscopy has also been used to analyze if R67 DHFR
possesses a proton donor in the active site. Using Raman spectroscopy, the N5=C6
stretch frequency has been measured for various dihydropterin-enzyme complexes. The
frequency of this bond is 1655 cm –1 when DHF is in buffer, pH 7. The pKa of DHF in
solution is 2.59;therefore, this frequency corresponds to the unprotonated form of DHF.
Protonation of the N5 of the pteridine ring results in a frequency of 1675 cm-1 while
deuteration of N5 shifts the frequency of the N5-C6 bond to 1660 cm-1. These
parameters were used to analyze the protonation state of DHF in the R67 DHFR reaction
(21). When the Raman spectra for the R67 DHFR• NADP+ (pH 7) complex is subtracted
from the R67 DHFR•NADP+•DHF spectra (pH 7) for samples in water or D20, no
deuterium shift is observed for the N5=C6 stretch mode. The peak in the difference
raman spectra occurs at a similar frequency to that of DHF in buffer, pH 7. Thus, the
absence of a deuterium shift indicates DHF is unprotonated in this ternary complex (21).
The pH-rate profile of the H62C mutant, Raman spectroscopy, and X-ray
structure of R67 DHFR are consistent with the absence of a proton donor in the active
site (21, 33). Surrounding solvent must therefore donate a proton to the N5 of DHF to
facilitate catalysis (21).
Active Site and Catalysis
R67 DHFR lacks a specific binding pocket characteristic of efficient enzymes.
Instead, it possesses a solvent exposed active site pore and lacks active site residues that
penetrate deep into the pore (10). In contrast, chromosomal DHFR utilizes residues in
the active site to form a binding pocket in which substrate and cofactor are differentially
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bound and creates a hydrophobic environment for hydride transfer. Typical distances for
hydride transfer are between 2.6-2.75 Å (34). Both the hydrophobic binding pocket and
the presence of a proton donor in the active site allow the chemistry of E.coli
chromosomal DHFR to be carried out at a much faster rate than R67 DHFR allowing it a
higher catalytically efficiency at pH 7: chromosomal DHFR has a hydride transfer rate of
238 s-1 (35) vs. 1.3 s-1 for R67 DHFR (7). This is also reflected by the difference in the
rate-limiting steps between these enzymes, product release for chromosomal vs. hydride
transfer for R67 DHFR (7, 36).
R67 DHFR utilizes a different catalytic strategy than chromosomal DHFR. A set
of core residues not only form the active site and make contacts with the ligands but also
generate a binding site that possesses the potential for overlapping binding sites. This
maximizes interligand contacts. This has previously been called “hot spot binding”(14,
37). For this enzyme to carry out catalysis, interligand contacts are crucial since the
active site residues possess dual roles in binding both NADPH and DHF. This
hypothesis is supported by kinetic characterization of proteins possessing mutations in
the active site, which effect binding of both NADPH and DHF equally. In addition, the
cooperativity patterns between the various ligands suggest interligand interactions are
highly important (14). From these studies, it appears that R67 DHFR is a primitive yet
important enzyme, as it provides a survival mechanism for its host E.coli in the presence
of trimethoprim.
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Insight into the Catalytic Mechanism of R67 DHFR
Conformation of NADPH and DHF in the Active Site
Measurements of intraligand nuclear Overhauser effects (NOEs) in NADPH
indicate that there are few interactions between the different moieties of NADPH (38). In
addition, this NMR data indicates that the conformation of the nicotinamide ring is syn
with respect to its ribose ring due to NOEs between protons in each moiety (39). Few
NOEs occurred between the atoms in DHF as well. Lack of extensive NOEs between the
atoms in each molecule suggests that NADPH and DHF are bound in extended
conformations in the active site.
Ligand-Ligand Interactions between NADPH and DHF
Interligand nuclear Overhauser effects (ILNOEs) were examined using the ternary
complex R67 DHFR•NADP+•folate incubated in the presence of D2O. Interatomic
distances were measured from 2-D NOESY spectra generated by cross-peaks between the
protons of folate and NADPH (38). These measurements reveal that interligand
interactions occur between the nicotinamide ring of NADP+ and the pteridine ring of
folate, with less than 4Å between them. A model for ligand binding in the active site of
R67 DHFR can be generated using this data, in which there is overlap of the pteridine
ring of folate and the nicotinamide ring of NADPH (38, 39). Lack of ILNOEs between
the tails of NADPH and folate suggest that these ligands enter the pore from opposite
ends and meet in the middle.
Stereochemistry of Hydride Transfer
Additional information about ligand conformation in the active site of R67 DHFR
comes from NMR studies examining the stereochemistry of hydride transfer (40).
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Labeled NADPH containing a pro-S deuterium and a pro-R hydrogen at the C4 of the
nicotinamide ring was incubated with DHF and R67 DHFR. Following incubation,
oxidized NADP+ was isolated using chromatography. 1H NMR spectroscopy of the
labeled, reacted NADP+ was compared to commercially available NADP+. The spectra
revealed that a pro-S deuterium remained at the C4 position of the reacted NADP+
indicating that the pro-R hydrogen had been transferred to DHF (40). R67 DHFR, like
chromosomal DHFR, transfers the pro-R hydrogen of NADPH to DHF. From the x-ray
structure of folate bound to R67 DHFR, the pteridine ring of folate (Fol I, the
productively bound folate in the pore) is positioned in the center of the pore with its si
face accessible to receive the hydride from NADPH thus allowing catalysis to occur (10).
Specifically, C6 of the si face of the pteridine ring of folate accepts the pro-R hydrogen
from NADPH.
NMR model for the Transition State of R67 DHFR
The combination of NOEs due to the intraligand interactions, ILNOEs identifying
interactions between DHF and NADPH, and isotope experiments describing the
stereochemistry of hydride transfer, is consistent with the substrate and cofactor adopting
an endo conformation in the transition state for R67 DHFR (38, 39). Quantum
mechanical calculations have been performed which predict the endo conformation is
favored by 2-8 kcal/mol over the exo conformation for the DHFR reaction (31, 41).
In the endo conformation there is extensive overlap of the molecular orbitals of
the donor and acceptor atoms in the nicotinamide and pteridine rings (C4 of NADPH and
C6 of DHF). This is achieved by partial stacking between the nicotinamide and pteridine
ring systems (34). The exo conformation results from hydride transfer in which there is
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little overlap between the molecular orbitals of the donor and acceptor atoms (42). Thus,
the exo transition state can be described as a conformation in which the nicotinamide ring
approaching the pteridine ring at an angle such that the hydride ion is adjacent to the
accepting C6 atom of the pteridine ring while there is no contact between the rings
(Figure 5).
Computational Predictions of Ligand Binding and the Active Ternary Complex
Further insight into the conformation of the ligands in the active site was gained
from computational studies of R67 DHFR using DOCK 4.0, which scores conformational
predictions based on van der Waals distances (43). This type of analysis led to
predictions of NADPH binding in the active site of R67 DHFR. First, the NMN moiety
of NADPH was docked into the R67 DHFR• FolI complex (43). The position of the
pteridine ring of folate in the active site comes from fitting of the electron density of
bound folate in the crystal structure of R67 DHFR. While the structure has 2 folates
bound in the active site, FolI was used for the docking studies, as it is the productively
bound folate (i.e. has its si face in position to accept a hydride whereas FolII has its face
towards the side of the pore and would be unable to accept a hydride) (10). Eight out of
the top ten docked NMN conformers docked into the active site in an orientation
consistent with previous experimental data: a) NMN had a syn geometry with respect to
the ribose and nicotinamide ring (39). b) NMN was in an orientation compatible with
pro-R hydride transfer (40). c) NMN docked in a conformation such that if the tail of
NADPH were added it would be on the opposite side of the pore as the glutamate tail of
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Figure 5. Endo versus exo transition state models. R67 DHFR is proposed to use the
endo transition state for catalysis as it is predicted to be more favorable by 2-8 kcal/mol
over the exo transition state (41). The nicotinamide ring is indicated in yellow in the
endo transition state and in purple in the exo transition state. The pteridine ring is shown
with carbon in green, nitrogen in blue, hydrogens in white, and oxygen in red. In the
endo conformation there is maximal overlap of the groups involved in hydride transfer,
C4 of the nicotinamide ring and C6 of the pteridine ring, due to ring stacking. In the exo
conformation, the nicotinamide ring approaches the pteridine ring at an angle, resulting in
almost no overlap between the rings (43).
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folate. This agrees with ILNOE data that suggests the ligands bind in an extended
orientation with no overlap of the tails (38, 39). d) The transition state adopted by the
R67 DHFR •Folate•NMN docked complex is consistent with an endo conformation,
which has been suggested to be more stable than the exo conformation (31, 41).
A similar series of experiments were carried out to predict the orientation of DHF
within the active site using the top-scoring NMN candidate from the
R67 DHFR•NMN•FolI complex (43). Twenty-one out of twenty-five of the top scoring
conformers placed the pteridine ring of DHF in the same orientation as the pteridine ring
of FolI (the productively bound folate) in the crystal structure of R67 DHFR (43).
Variation was observed in the dockings of DHF with respect to the PABA-Glu tail (paraaminobenzoic acid). Multiple orientations of the tail of DHF predicted by DOCK agree
with the disorder observed for this moiety in the crystal structure with R67 DHFR as well
as with NMR data that indicate the glutamate tail of DHF tumbles in solution (10, 38).
Finally, NADPH was docked into the active site using the R67 DHFR•FolI
complex. The conformer most consistent with previous experimental data ranked 33 out
of the top 100. This conformer of NADPH possesses a syn geometry for the carboxamide
and ribose ring and an anti conformation about the adenine and ribose rings (38-40, 43).
Due to the low ranking of the NADPH docked structure as well as it being the only
conformer in the orientation consistent with experimental data, there is less confidence in
its docked orientation. The results of these computational studies indicate that the ligands
of R67 DHFR bind in an overall extended conformation and possess flexibility with
respect to the glutamate tail of DHF (10, 38, 43). Together, NMR and docking studies
support the hypothesis that R67 DHFR uses an endo transition state to accomplish
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hydride transfer of the pro-R hydrogen of NADPH to C6 on the si face of the pteridine
ring on DHF (10, 38-40, 43).
Active Site Residues and Their Role in Ligand Binding
R67 DHFR is interesting as it has a single active site pore made up by four
subunits. Residues that line the pore in each monomer are K32, Y46, T51, S65, V66,
Q67, I68, and Y69 (Figure 2). A combination of structural, NMR, docking, and sitedirected mutagenesis studies has proved invaluable for assessing the role of these
residues in binding and catalysis (10, 14, 43, 44) (Narayana, personal communication).
Although some structural data exists, it is only with folate. Folate is similar in structure
to DHF with the exception of a double bond between C7 and N8. Hence, the data
directly observed for folate binding can likely be applied to DHF binding. While an xray structure for NADPH binding has not been obtained, several studies have been
conducted to predict a binding mode that leads to an active ternary complex with DHF in
the active site of R67 DHFR (38, 43, 44) (Narayana, personal communication).
In the crystal structure, K32 is not observed to directly bind to folate. However,
the electron density for the para-aminobenzoic acid glutamate tail is such that the
positions of these moieties could not be observed (10). Yet, it is predicted by docking
studies to be involved in an ionic interaction with the glutamate carboxylate groups on
the tail of DHF (43). It is also hypothesized to be involved in ionic interactions with the
2’ phosphate off the hydroxyl of the AMP ribose as well as with the pyrophosphate
bridge of NADPH (10, 43, 44) (Narayana, personal communication). These predictions
however, will be tested experimentally.
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Mutagenesis and kinetic characterization of Y46 (Y46F) and S65 (S65A) indicate
these residues are not crucial for binding either NADPH or folate (14). Accordingly, an
interaction between these residues and folate was not observed in the crystal structure.
However, indirect interactions between the hydroxyl groups of these residues and folate
through intermediary water molecules are possible (43).
V66 is involved in a hydrogen bond with the N8 of folate through an intermediary
water (10). It is predicted to form hydrogen bonds with the N5 and N6 atoms of the
pteridine ring of NADPH through its backbone oxygen (43).
Four symmetry related Q67 residues line the pore forming a “ceiling” and a
“floor”. Crystal structure data reveal this residue is involved in van der Waals
interactions with the pteridine ring of folate (10). Q67 is predicted to form van der Waals
interactions with the nicotinamide ring of NADPH as well as a hydrogen bond with the
ribose hydroxyl of NADPH at the O2’ position (43). Mutation of this residue leads to
severe cofactor and substrate inhibition due to ready formation of the 2 NADPH and 2
DHF non-productive complexes. Thus, this residue is also involved in establishing the
cooperativity of ligand binding (23, 45).
I68 is involved in a hydrogen bond through its backbone amide to the 4-oxo group
of folate as well as with the N8 of folate through an ordered water molecule in the active
site (water 124) (10). In agreement with the structural data, mutagenesis of this residue
to either methionine or leucine results in approximately a 4-fold or 8-fold decrease in the
binding affinity for DHF (14). I68 is predicted to be involved in a hydrogen bond with
the carboxamide group of the nicotinamide ring. In agreement with these predictions,
mutagenesis of this residue results in an 8-fold increase in the Km (NADPH) (14, 43).
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A direct interaction between Y69 and folate is not observed in the crystal
structure. Yet, it may form a hydrogen bond with the tail of folate through an
intermediary water. Y69 is predicted to be involved in a hydrogen bond (through a water
molecule) to an oxygen off the pyrophosphate bridge of NADPH. It is also predicted to
be involved in van der Waals interactions using its CD1 and CE1 atoms with the ribose
hydroxyl groups (43). Kinetic studies with the Y69F mutant, which results in the
removal of hydrogen bonding potential, results in a 12-fold decrease in
Km (NADPH) (14) (Stinnett, unpublished results).
Kinetic characterization of R67 DHFRs that possess mutations of residues, which
reside in the active site, reveal that binding of both NADPH and DHF are effected
equally. Therefore, it appears this enzyme uses its symmetry for binding either ligand in
related sites (14, 23)(Hicks, unpublished results).
Electrostatics and R67 DHFR Binding/Catalytic Mechanism
Electrostatics have been illustrated to be crucial for many different aspects of
protein folding/structure and enzymatic processes. Charge-charge interactions have been
implicated in providing protein stability in halophiles, as well as mesophiles (46). Yet,
charge-charge interactions can also be destabilizing as the energetic cost of desolvation
may exceed the enthalpic contribution of these interactions. This is observed in Bruce
Tidor’s work using computational approaches to predict energetic values of salt bridges
in proteins (47-49). Electrostatics have also been demonstrated to be important in
attracting ligands to the active site. DELPHI, a finite Poisson-Boltzmann difference
solver, is commonly used to predict electrostatic potentials of enzymes (50). This
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computational algorithm predicts that R67 DHFR possesses a positive electrostatic
potential at the active site generated by lysine 32 (K32) and lysine 33 (K33) (43)
(Figure 6). Mutagenesis of these residues using the computer program INSIGHT, results
in a loss of the positive electrostatic potential at the active site. K32, which is located
closer to the active site than K33, however seems to play a more significant role in
generating the potential. This is apparent from the drastic reduction in the positive
electrostatic potential at the active site that results from computational mutagenesis of
K32 to methionine (43).
Positive electrostatic potentials have been predicted to be utilized by several
DHFRs to attract the negatively charged ligands NADPH (-3) and DHF (-2) to the active
site. This includes, E.coli, S.faecium, L.casei, Mus musculus, human, and bovine DHFRs
(51). Enzymes other than DHFRs have also been predicted to utilize electrostatic
potentials to influence ligand binding such as superoxide dismutase, barnase, and
acetylcholine esterase (50, 52).
A common technique employed to analyze the role of electrostatics in ligand
binding and catalysis is salt effects. Salt sensitivity of kinetic and thermodynamic
parameters is indicative that ionic interactions are involved in these processes. Ionic
interactions are the strongest electrostatic interactions. This is reflected by a distance
dependence of 1/r compared to a distance dependence of 1/r3 for charge-dipole
interactions and 1/r6 for dipole-dipole interactions (53). Not only can the involvement of
ionic interactions in ligand binding be studied, the number of ionic interactions involved
can be quantitated. This was first reported in 1976 by Record et al, and more recently in
2001 by Park and Raines (54, 55). In 1976, Record et al described several studies of the
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Figure 6. DELPHI predictions of the electrostatic potential of R67 DHFR. (A).
DELPHI predicts that R67 DHFR possesses a positive electrostatic potential at the active
site generated by K32 and K33. Regions of negative electrostatic potential are depicted
in red, neutral in white, and positive electrostatic potential in blue. The units for the
electrostatic potential are kT. (B). Computational mutagenesis of K33 results in a minor
decrease in positive electrostatic potential at the pore. (C). Computational mutagenesis
of K32 results in a significant decrease in the positive electrostatic potential. (D).
Mutagenesis of both K32 and K33 results in a negative electrostatic potential on the
surface of R67 DHFR (43).
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salt sensitivity of oligonucleotide and DNA binding to ribonuclease A (RNase A). The
Kd values for both DNA and oligonucleotide binding increased with increasing salt
concentration. This illustrated that the charged moieties of these molecules, the
negatively charged phosphates, were involved in ionic interactions with cationic residues
in RNase A. In fact, a linear correlation was observed for the logarithm of the Kd vs. the
logarithm of the salt concentration. This demonstrates there is a relationship between salt
concentration and ligand binding affinity. The slope of this log-log plot is linearly
proportional to the number of ionic interactions involved in binding, i.e. the number of
ionic interactions between RNase A and the phosphates in DNA (54).
Recently, Park and Raines described the application of salt effects to enzyme
catalysis using RNase A as a model system (55). These studies monitored
oligonucleotide binding to wild-type (wt) RNase A as well as the RNase A mutants
K7A/R10A/K66A and K41R. A linear correlation was observed for log-log plots of
kcat/Km of wt and mutant RNase A vs. salt concentration illustrating the salt dependence
of this kinetic parameter. The slopes of these log-log plots are ascribed to the number of
ionic interactions involved in binding phosphate groups of the oligonucleotide. Slopes of
the log-log plots quantifying the number of ionic interactions involved in phosphate
binding are consistent with the X-ray structure of ribonuclease A bound to the
oligonucleotide d(ApTpApApG) identifying the phosphate binding sites (55).
This type of interpretation is similar to that of the slopes of pH-rate profiles. The
typical acid-base catalyst possesses a bell shaped pH-rate profile. This shape is produced
by an inflection point at a pH where the maximal kcat/Km occurs followed by a linear
decline in kcat/Km with increasing and decreasing pH. The slopes of the linear portion of
26

log kcat/Km vs. log pH plots are equal to the number of titratable groups involved in
catalysis (55). Similarly, the slopes of log-log plots of Kd or kcat/Km vs. ionic strength are
equal to the number of ionic interactions involved in binding. Salt studies have also
proved useful for the elucidation of the binding mechanism of a number of other proteins
including NS3 hepatitis C protease, cytochrome P450 reductase, vitronectin, Syk Kinase,
and antithrombin (56-60). This approach is also being used to investigate the number of
ionic interactions involved in binding and catalysis for R67 DHFR.
While this type of analysis can be very insightful, there are several criteria that
must be met to obtain meaningful results 1) The salt concentration of the buffer should
not significantly affect the structure of the enzyme. 2) Salt should not significantly affect
the pKa of the substrates and thereby produce an artificial effect on binding/catalysis. 3)
Alternative anions should result in the same slope of log-log plots of kinetic parameters
vs. ionic strength. 4) The rate-limiting step should be the chemistry step of the reaction.
5) Slopes of log-log plots of Kd vs. ionic strength should agree with log-log plots of the
kinetic parameters (55).
Charged Residues in R67 DHFR
Only two charged residues occur near the active site of R67 DHFR, K32 and K33.
In addition to their predicted role in generating a positive electrostatic potential at the
active site or R67 DHFR, docking and NMR data suggest K32 is involved in an ionic
interaction with the 2’phophate off the hydroxyl of the AMP ribose ring as well as with
the pyrophosphate bridge of NADPH (43, 44) (Narayana, personal communication).
Early predictions of the involvement of this residue in binding NADPH led to
experiments to test its role. Mutation of K32 to the non-polar amino acid alanine was
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deleterious to the quaternary structure of R67 DHFR, resulting in an inactive dimer
(Hamilton, masters thesis) as demonstrated using both molecular sieving and pH titration
experiments. Kinetic characterization of the dimeric form of K32A proved difficult, but
revealed that in addition to the structural effects of this mutant, there is a significant
decrease in the kinetic parameters of the K32A mutant compared to other dimeric
mutants, H62C (reduced) (33) and W38F R67 DHFR (61).
K33 is located on the surface of the enzyme and in addition to its predicted role in
generating a positive electrostatic potential at the active site of R67 DHFR, it may also
facilitate cofactor and substrate binding directly or by positioning K32 in the proper
orientation to make ionic contacts with the ligands.
Quadruplication of R67 DHFR to Examine Asymmetric Mutations
Four gene copies of R67 DHFR have been linked in frame (23, 45) to introduce
asymmetry into the active site of R67 DHFR. This will allow examination of the effects
of mutations in individual domains to analyze specificity of interactions as well as the
role of interligand cooperativity. Originally, this protein was constructed without unique
restriction sites between gene copies. This resulted in the inability to specifically mutate
individual domains of R67 DHFR (45). To circumvent this problem, a new
quadruplicated gene of R67 DHFR was generated (23). This molecule possesses unique
restriction enzyme sites engineered between the gene copies to allow for mutagenesis of
an individual gene copy and ligation back into the construct. In this way, mutations can
be generated asymmetrically in R67 DHFR.
The protein product of this construct, Quad2, is four times the molecular mass of
monomeric R67 DHFR and is quite active, possessing kcat and Km values similar to those
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of wt R67 DHFR. A seventeen amino acid linker sequence corresponding to the native
amino terminus has been used to tether the gene copies of R67 DHFR resulting in a
protein product that consists of domains tethered together where each domain
corresponds to a monomer in wt R67 DHFR. However, one concern with this
quadruplicated gene product was topology switching. The linker sequence tethering
domains 2 and 3 is long enough to allow the formation of an alternative conformation
where domain 2 is adjacent to domain 4. In this case, it would be impossible to study
effects of asymmetric mutants since the orientation of domains 3 and 4 would be
unknown.
Using crystal structure data which indicates that H62 pairs with S65 at the dimerdimer interface of R67 DHFR, complementation experiments were performed by Dam et
al. with S65A mutants that form inactive dimers and H62L mutants that form inactive
dimers. Mixing S65A dimeric mutants and H62L dimeric mutants results in the
formation of an active R67 DHFR hetero-tetramer (13). This strategy was used with the
four-gene copy construct of R67 DHFR that was linked in frame to produce a tethered
protein, Quad3, which lacked the ability to undergo topology switching. This protein
thus contained an H62L mutation in gene copy 4 and an S59A mutation in gene copy 1.
Flip-flopping of domains 3 and 4 would result in the pairing of a hydrophobic residue
with a polar residue, which is unfavorable. Thus, this is a useful system for studying the
effects of asymmetric mutations on ligand binding, catalysis, and cooperativity.
Focus of Research Studies
While some insight into the catalytic mechanism of R67 DHFR has been gained,
there are still many unanswered questions. The focus of this dissertation is to investigate
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the role of ionic interactions in ligand binding and catalysis of R67 DHFR. NMR and
docking predictions of the involvement of K32 in ionic interactions led the way for
experimental testing of this hypothesis. To evaluate the importance of ionic interactions
in binding/catalysis, salt effects on K33M and wt R67 DHFRs were examined since
mutagenesis of K32 in the R67 DHFR homotetramer results in the formation of inactive
dimers. The role of the charged moieties of NADPH, the phosphate at the 2’ position off
the AMP ribose and the pyrophosphate bridge, in ionic interactions with R67 DHFR have
also been evaluated. Generation of a four-gene copy construct of R67 DHFR, which is
linked in frame, provided an opportunity to directly test the hypothesis that K32 is
involved in ionic interactions with the ligands. From these studies, several discoveries
have been made describing (1) a role for ionic interactions involved in ligand binding and
catalysis, (2) the contribution of the 2’phosphate vs. the pyrophosphate bridge of NADPH
and the glutamate moiety of the PABA-Glu tail of DHF, (3) the importance of the
symmetry of the R67 DHFR active site for ionic interactions, and (4) the involvement of
K32 in ionic interactions in R67 DHFR.
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sequence. This enzyme is a homotetramer, when a single residue is mentioned; all four
related residues are implied.
Abstract
R67 dihydrofolate reductase (DHFR), which catalyzes the NADPH dependent
reduction of dihydrofolate to tetrahydrofolate, belongs to a type II family of R-plasmid
encoded DHFRs that confer resistance to the antibacterial drug, trimethoprim. Crystal
structure data reveals this enzyme is a homotetramer that possesses a single active site
pore. Only two charged residues in each monomer are located near the pore, K32 and
K33. Site-directed mutants were constructed to probe the role of these residues in ligand
binding and/or catalysis. As a result of the 222 symmetry of this enzyme, mutagenesis of
one residue results in modification at four related sites. All mutants at K32 affected the
quaternary structure, producing an inactive dimer. The K33M mutant shows only a 2-4
fold effect on Km values. Salt effects on ligand binding and catalysis for K33M and
wildtype R67 DHFRs were investigated to determine if these lysines are involved in
forming ionic interactions with the negatively charged substrates, dihydrofolate (overall
charge of -2) and NADPH (overall charge of -3). Binding studies indicate two ionic
interactions occur between NADPH and R67 DHFR. In contrast, binding of folate, a
poor substrate, to R67 DHFR•NADPH appears weak, as a titration in enthalpy is lost at
low ionic strength. Steady state kinetic studies for both wild type (wt) and K33M R67
DHFRs also support a strong electrostatic interaction between NADPH and the enzyme.
Interestingly, quantitation of the observed salt effects by measuring the slopes of the log
ionic strength vs. the log kcat/Km plots indicates only one ionic interaction is involved in
forming the transition state. These data support a model where two ionic interactions are
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formed between NADPH and symmetry related K32 residues in the ground state. To
reach the transition state, an ionic interaction between K32 and the pyrophosphate bridge
is broken. This unusual scenario likely arises from the constraints imposed by the 222
symmetry of the enzyme.
Introduction
Dihydrofolate reductases (DHFRs) are ubiquitous enzymes that catalyze the
NADPH dependent reduction of 5,6-dihydrofolate (DHF) to form 5,6,7,8-tetrahydrofolate
(THF). The formation of THF is important since it is a precursor for purine nucleosides,
methionine, and many other metabolites (1). Thus, inhibition of this enzyme results in
disruption of DNA synthesis and consequently cell death. Trimethoprim (TMP) is a
clinically important inhibitor of bacterial DHFRs. However, R67 DHFR, a type II Rplasmid encoded DHFR, confers resistance to TMP upon its hosts. This enzyme has no
sequence or structural homology to other known DHFRs. Therefore, to gain more
insight into the catalytic mechanism of this enzyme, the role of ionic interactions in
ligand binding and catalysis was investigated.
The crystal structure of R67 DHFR was previously solved by Narayana et al., (2).
Each monomer is a five stranded β–barrel consisting of 78 amino acids that self-associate
to form the active tetramer. R67 DHFR contains a single active site pore formed from
each of the four identical subunits (Figure 1). This pore possesses 222 symmetry and
contains four possible binding sites. Due to steric constraints, the pore can only
accommodate two ligands simultaneously. Two folate molecules were observed by time
resolved fluorescence anisotropy and isothermal titration calorimetry (ITC) data to bind
in the pore. ITC also revealed that only two NADPH molecules bind in the pore (3). The
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K32

K33

Figure 1. The active homotetrameric form of R67 DHFR is formed by the selfassociation of four identical subunits, A (blue), B (green), C (magenta), and D (red). K32
and K33 residues are shown in CPK format and one set of the symmetry related residues
are labeled at the lower right. The side chain of K32 projects into the active site pore
while K33 is located on the surface of the protein with its side chain projecting away
from the active site pore. Two K32 and two K33 residues occur on one end of the pore
pointing toward the viewer (lower right and upper left), while two symmetry related pairs
occur on the other end of the pore, pointing away. The position of the ligands in the
central pore is shown in stick format. The pteridine ring of folate (bottom) comes from
the crystal structure (2), while that of the NMN moiety of NADPH (bottom) derives from
docking studies (4). Carbon atoms are shown in green, oxygen atoms in red, nitrogen
atoms in blue, and phosphate in magenta.
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active ternary complex consists of one molecule of NADPH and one molecule of DHF.
Preferential formation of the active complex occurs due to negative cooperativity in
binding between NADPH molecules and positive cooperativity between DHF and
NADPH molecules (3).
Because of the symmetry of R67 DHFR, the active site pore is lined with a
limited number of residues that can participate in catalysis including lysine 32, tyrosine
46, threonine 51, serine 65, valine 66, glutamine 67, isoleucine 68, and tyrosine 69 (2).
Lysine 32 (K32) in each monomer is located near the dimer-dimer interface. The
sidechain NZ atom of K32 participates in hydrogen bonds with the backbone carbonyl
groups of serine 34 and alanine 36 in a symmetry related monomer (2). The orientation
of the K32 residue in each monomer is such that the side chain projects into the active
site pore and has the potential to participate in ligand binding and catalysis (Figure 1).
One proposed role of K32 is an ionic interaction with the 2’phosphate off the AMP ribose
ring of NADPH ((4) and Narayana, personal communication). In order to understand the
role of the K32 residues in ligand binding, this residue was mutated to alanine, arginine,
glutamine, and methionine. These mutations were made to either eliminate the
possibility of an ionic contact with the substrates and/or to vary the potential for
hydrogen bonding.
Lysine 33 (K33) is located on the surface of the enzyme with its side chain
projecting away from the protein (Figure 1) (2). K33 was also mutated to the nonpolar
uncharged residue, methionine. Since K32 and K33 are the only charged residues near
the active site pore of wt R67 DHFR, mutagenesis of these residues to methionine allows
investigation of their importance in forming ionic interactions with the substrates
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NADPH and DHF. If these residues are involved in an ionic contact(s) with the
negatively charged substrates, then their replacement should result in weaker binding.
The importance of K32 and K33 in binding and catalysis is also illustrated by
their conservation in type II DHFRs (5). Additionally, both K32 and K33 are proposed
by DELPHI, a finite Poisson-Boltzmann difference solver, to be involved in generating a
positive electrostatic potential at the active site which attracts the negatively charged
substrates (NADPH and DHF) and facilitates binding (4).
Materials and Methods
Mutagenesis
A synthetic R67 DHFR gene, cloned into a pUC8 vector (6), was used for PCR
mutagenesis reactions. The oligonucleotide primers for the coding strand used to
generate mutations in the R67 DHFR gene corresponding to the amino acid positions 32
and 33 using the Stratagene QuikChange Mutagenesis Kit were as follows:
5’GGGTGACCGCGTACGTAAAAAATCCGGAGCCGCC3’ (K32A),
5’GGGTGACCGCGTACGTAGGAAATCCGGAGCCGCC3’ (K32R),
5’GGGTGACCGCGTACGTCAGAAATCCGGAGCCGCC3’ (K32Q),
5’GGGTGACCGCGTACGTATGAAATCCGGAGCCGCC3’ (K32M),
5’GGGTGACCGCGTACGTAAGATGTCCGGAGCCGCC3’ (K33M).
Mutants were verified by automated fluorescence DNA sequencing at the University of
Tennessee DNA Sequencing Facility using an ABIPRISM Dye Terminator Cycle
Sequencing Kit from Perkin Elmer. Subsequently, R67 DHFR mutants were transformed
into the SK383 strain of E.coli for protein expression (6, 7).
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Protein Purification
Mutant R67 DHFR genes were expressed, and the protein was purified from
E.coli grown to late stationary phase in TB media (8) at 37°C in the presence of 200
µg/ml ampicillin and 20 µg/ml trimethoprim (TMP). K32M mutants were sensitive to
the presence of TMP and therefore were first grown to visible turbidity before TMP
addition. Purification was achieved by a series of steps including G-75 Sephadex,
DEAE-Fractogel, and Hi-Q column chromatography. The final step of the purification
procedure consisted of FPLC column chromatography using a Mono-Q anion exchange
column. Purified protein was dialyzed into deionized water and lyophilized for storage at
–20°C.
Molecular Sieving Studies
To determine the apparent molecular weights of the K32A, K32M, and K33M
mutant proteins, gel filtration using a Superose 12 (HR 10-30) column on a Pharmacia
FPLC was performed at 4°C. These studies were conducted at both pH 8 and pH 5 in
MTA buffer (50 mM Mes, 100 mM Tris, 50 mM Acetic acid). This buffer maintains a
constant ionic strength (µ = 0.15) from pH 4-10 (9). The Kav = (elution volume - void
volume)/(bed volume – void volume) was calculated for protein standards from the
Pharmacia Gel Filtration Calibration Kit to generate a standard curve from which the
molecular weight of R67 DHFR variants was determined.
Circular Dichroism
Circular dichroism (CD) spectra were recorded at 22°C in 10 mM potassium
phosphate buffer, pH 5 and 8 with 10 µM wild type, K32M, or K33M R67 DHFRs using
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an Aviv Model 202 Series circular dichroism spectrometer. Data were collected from
190 nm to 250 nm using a cuvette pathlength of 1.0 mm. Each spectrum was generated
using 1nm steps with an integration time of 2 seconds. A buffer baseline was subtracted
from each scan and data were subsequently converted to molar ellipticity (θ) using 108
g/mole as the mean residue molecular weight.
pH Dependence of Oligomeric-State
Tryptophan residues were used to monitor the intrinsic fluorescence of the lysine
mutants as compared to wild-type protein to determine the pH dependent tetramer to
dimer equilibrium. The model for the pH dependent equilibrium of R67 DHFR is:
Koverall
T + 2nH+⇌ 2DHn

(1)

where T is tetramer, D is dimer, DHn is protonated dimer and Koverall equals Ka2n/Kd. This
model is based on the findings of Nichols et al., (10), where dissociation of tetramer into
dimers is linked to the protonation of symmetry related H62 residues located at the
dimer-dimer interfaces.
Fluorescence measurements were made using a Perkin-Elmer LS-5B spectrometer
interfaced to an IBM PS/2 computer. Tryptophan residues were excited at 295 nm and
emission was monitored from 300 to 450 nm using 2 µM of wt, K32M, or K33M R67
DHFRs in MTA polybuffer. Each sample was titrated with small aliquots of 1N HCl and
the pH was measured over the range of pH 8-4. The intensity averaged emission
wavelength, <λ>, for each emission spectrum was calculated using:
<λ> = Σ(Iiλi)/Σ(Ii)

(2)
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where I is intensity, and λ is the wavelength (11). The fluorescence data were fit to
equation 5 in Nichols et al., (10) using a non-linear regression subroutine of the Statistical
Analysis Systems package (SAS, Cary, NC). Finally, fitting to the following equation
normalized the data:

Fapp = (Yobs-YpH8)/(YpH4-YpH8)

(3)

where Fapp is a fractional value between 0 and 1, and Yobs, YpH8, and YpH4 are the optical
values associated with the observed pH and with the pH limits of 8 and 4, respectively.
This same analysis was performed with 2 µM wild-type R67 DHFR in MTA
buffer pH 8 (µ=0.15). NaCl was added to adjust the ionic strength to 0.25, 0.5, and 0.75
to determine salt effects on the pH dependent oligomerization of wild-type R67 DHFR.
Fluorescence Quenching
Binding of NADPH to 2.5 µM R67 DHFR was monitored in TE buffer (10 mM
Tris, 1 mM EDTA, pH 7) using tryptophan fluorescence as per Zhuang et al. (12). Data
were fit to:

Fl = Fo – 0.5 Fo [Ptot + Kd + Ltot – [(Ptot + Kd + Ltot)2 – 4 Ptot Ltot)1/2]

(4)

where Fl is the observed fluorescence, Ltot is the total ligand concentration, and Ptot, Kd
and Fo are variables describing the number of enzyme binding sites, dissociation constant,
and fluorescence yield per unit concentration of enzyme, respectively (13).
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Isothermal Titration Calorimetry
ITC experiments with NADPH or folate as titrant were performed in TE buffer
pH 7 at 28°C in the presence of NaCl to adjust the ionic strength. Protein concentrations
used for these experiments varied between 100-150 µM. Binding affinities and
enthalpies associated with binding were measured as previously described (3). Binding
of NADPH or folate to wt R67 DHFR was measured using a Microcal VP isothermal
titration calorimeter. The data were collected by an IBM personal computer running
DSCITC Software and were fit using Origin version 5.0 software. Baseline correction of
the data was performed by injecting ligand into buffer. ITC was also done with the
K33M mutant to determine the ∆H and the associated Kd values for NADPH binding in
MTA buffer pH 8. Finally, binding of folate to a 1:1 mix of R67 DHFR:NADPH was
performed at 13oC (in TE buffer, pH 7) as previously reported (3). Instrument design and
operation are explained by Wiseman et al., (14).
Kinetic Analysis
Steady-state kinetic data for the K33M mutant were obtained using the computer
program UVS (Softways) on a Perkin-Elmer λ3a spectrophotometer interfaced with an
IBM PS/2 (15). Kinetic assays were performed at 30°C in MTA polybuffer pH 7. The
kinetic parameters Km (DHF), Km (NADPH) and kcat were determined under subsaturating
conditions by maintaining a constant concentration of one ligand while varying the
concentration of the other ligand. This was done at five or more different subsaturating
ligand concentrations. Data were globally fit using a non-linear regression analysis
performed by SAS (16). The extinction coefficients used were 28,000 M-1cm-1 at 282 nm
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for DHF (17), 6220 M-1cm-1 at 340 nm for NADPH (18), and 12,300 M-1cm-1 at 340 nm
for the reaction (19).
Kinetic analysis was also performed to determine ionic strength effects on the
steady-state kinetics parameters for wt and K33M R67 DHFRs. These assays were
conducted at 30°C in TE buffer, pH 7 (µ = 0.02) with NaCl added to adjust the ionic
strength to 0.15, 0.22, 0.32, and 0.42. Salt effects were also examined using NaF (µ from
0.1 to 0.62) and NaSCN (µ from 0.1 to 0.18). Salt effects were also tested with wt R67
DHFR using the alternate cofactor, NADH. Kinetic assays were monitored at 360 nm to
allow use of higher ligand concentrations to bracket the Km values. Extinction
coefficients at this wavelength were calculated as 2630 M-1cm-1for DHF, 4020 M-1cm-1
for NADH, and 5020 M-1cm-1 for the reaction.
Results
Effects of Mutations
Molecular Sieving Studies
The K32A, K32M, K32Q and K32R mutants provided minimal resistance to
TMP, while the K33M mutant readily allowed cell growth in media containing TMP.
TMP sensitivity has previously been observed in mutants that destabilize the active
homotetramer (10, 20). Therefore, the oligomeric state of each purified mutant protein
was analyzed by the elution pattern on a molecular sieving column at pH 8 and 5. At pH
8, wt R67 DHFR elutes as a tetramer, however at pH 5, wt R67 DHFR elutes as a dimer
(10). The K32M and K32A mutants have approximate molecular weights at both pHs 8
and 5 that correspond to the dimeric form of R67 DHFR (Table 1). Since K32 occurs
near the dimer-dimer interface, these four symmetry related mutations have a cumulative
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Table 1. Molecular sieving experiments conducted with wt, K32M, and
K33M R67 DHFRs in MTH buffer pH 8 and pH 5.
DHFR Species
Molecular Weight Molecular Weight
(daltons)
(daltons)
WT R67 DHFR

pH 8
39,000 ± 810

pH 5
25,000 ± 120

K32A R67 DHFRa

29,000 ± 150

25,700 ± 980

K32M R67 DHFR

25,000 ± 120

25,000 ± 120

K33M R67 DHFR

37,000 ± 650

24,000 ± 800

a

Hamilton, thesis
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effect and destabilize the tetramer. In contrast, the K33M mutant has similar estimated
molecular weights at pH 8 and 5 to wt R67 DHFR, suggesting it maintains the
homotetrameric form over the pH ranges of our experiments.
Circular Dichroism
To examine the effect of the mutations on the secondary structure of R67 DHFR,
CD was performed at both pHs 8 and 5 (Figure 2). The mutants show smaller signals
compared to wt at both pH 8 and 5. In the case of the K33M mutant, this small
difference may be due to a change in the local environment that occurs as a result of the
mutation (21). The CD spectra, in addition to the molecular sieving and pH titration data,
illustrate that the K33M mutant is comparable to wt in conformation. On the other hand,
the K32M mutant shows a significant difference in the CD spectra consistent with the
molecular sieving and pH titration data that this mutant is dimeric.
pH Dependence of Oligomeric-State
To provide a more quantitative evaluation of the effect of the mutations on the
tetramer to dimer equilibrium, tryptophan fluorescence was monitored as a function of
pH. Specifically, the tryptophan 38 (W38) residues that occur at the dimer-dimer
interface can be utilized to monitor changes in the local environment since in the
tetrameric form of R67 DHFR these residues are buried in a hydrophobic environment,
whereas in the dimeric form of R67 DHFR these residues are solvent exposed. This
equilibrium is linked to the protonation of histidine residues. Titration of the four
symmetry related histidine 62 residues located at the dimer-dimer interfaces results in
protonation and destabilization of the tetramer into dimers (10).
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Figure 2. Circular dichroism spectra for wt, K33M, and K32M DHFRs. Panel A
illustrates the spectra for wt (
), K33M (
), and K32M (
), at pH 8. Panel B
illustrates the spectra for these proteins at pH 5.
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pH titrations for wt, K32M and K33M R67 DHFRs are shown in Figure 3. The
wt and K33M enzymes show a titration consistent with a tetramer (pH 8) to two dimers
(pH 5) transition. In contrast, the K32M (and K32A not shown) mutant does not,
consistent with it remaining dimeric throughout this pH range. The pH titration data for
wt and K33M R67 DHFRs were fit (10) and best-fit values are given in Table 2. The
Koverall value for the K33M mutant is similar to that for wt R67 DHFR where the best fit
occurs with 2n=3, and 2n represents the number of protons added to the dimer-dimer
interfaces resulting in dissociation of the tetramer. Since the K33 residues are located on
the surface of the protein at the edge of the active site pore, the mutation was expected to
have a minimal effect on the oligomeric state of the enzyme. Accordingly, the Koverall
values are similar to wt R67 DHFR.
Tryptophan fluorescence as a function of pH was also monitored with wt R67
DHFR in the presence of 0.25M, 0.5M, and 0.75M NaCl to determine the effects of salt
on the oligomeric state of the protein (Figure 4). Addition of salt slightly destabilizes the
tetramer. At pH 7, where most of the kinetic and binding experiments were performed,
the majority of the protein is tetrameric so any observed salt effects are not due to a shift
in the tetramer to dimer equilibrium.
Binding and Steady State Kinetic Analysis
Steady state kinetics were performed with wt and mutant DHFRs (Table 3).
Kinetic analysis of the K32M mutant could not be readily performed due to its low
activity. The low activity correlates with loss of the active site pore upon dimer
formation. Previous kinetic analysis of dimeric R67 DHFRs indicates low activity (10,
20); however the activity of the K32 mutants is even lower, suggesting an additional
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Figure 3. pH titrations of wt (c), K32M ( ), and K33M (U) R67 DHFRs to monitor
the pH dependence of the oligomeric state. At pH 8, wt R67 DHFR is a tetramer while at
pH 5 it is a dimer. Best fits are represented by a solid line for wt R67 DHFR and a
dashed line for K33M R67 DHFR (10). Koverall values are given in Table 2 for 2n=3.
Since the K32M data do not show a transition and the center of mass value corresponds
more closely to the wt dimer value, we conclude that the K32M mutant remains dimeric
throughout this pH range.
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Table 2. Best-fit values for the T + 2nH+⇌ 2DHn equilibrium
monitored by fluorescence.

WT R67 DHFR

Koverall (= Ka2n/Kd)
for 2n=3 in units of M2
2.5 x 10–13 ± 9.1 x 10-15

K33M R67 DHFR

1.1 x 10-13 ± 6.1 x 10-15

wt R67 DHFR (0.25M NaCl)

5.9 x 10-14 ± 2.9 x 10-15

wt R67 DHFR (0.5M NaCl)

3.8 x 10-14 ± 2.0 x 10-15

wt R67 DHFR (0.75M NaCl)

3.3 x 10-14 ± 1.5 x 10-15

DHFR Species/Condition
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Figure 4. Effects of increasing salt on the pH dependent oligomeric state of wt R67
DHFR were monitored at NaCl concentrations of 0M (c), 0.25M ( ), 0.5M (), and
0.75M(S). Addition of salt shifts the titration, however the effect is not great. Best-fit
values are given in Table 2.
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Table 3. A comparison of steady-state kinetic values for K33M
and wt R67 DHFRs in MTA buffer, pH 7.
DHFR Species
WT R67 DHFRa

Km (NADPH)
(µM)
3.0 ± 0.06

Km (DHF)
(µM)
5.8 ± 0.02

kcat
(s-1)
1.3 ± 0.07

K33M R67 DHFR

12 ± 1.8

14 ± 0.09

1.7 ± 0.13

a

from Reece et al., (6).
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affect of the mutation on binding and catalysis. In contrast, steady state kinetics could be
performed for the K33M mutant. This mutant displays a 2-fold increase in the Km for
DHF and a 4-fold increase in the Km for NADPH. There was also a slight increase in kcat.
Additionally, binding of NADPH to this mutant was monitored by ITC (Table 4).
Negative cooperativity is observed during NADPH binding, with one tight site and one
weak site. The K33M mutation weakens binding to these sites by 8- and 7-fold,
respectively. Together, these results suggest that K33, located on the surface of R67
DHFR, plays a minor role in binding both cofactor and substrate in the active site pore.
Ionic Strength Effects
Since the role of K32 could not be evaluated directly through a site-directed
mutagenesis approach, its ability to participate in ionic interactions was evaluated
through salt effects on wt and K33M R67 DHFRs. Ligand binding was first evaluated,
followed by steady state kinetic analysis.
Fluorescence Quenching with NADPH
The binding of NADPH as affected by ionic strength was determined by
monitoring fluorescence quenching. The sensitivity of this technique only allows
monitoring of binding at the first tight site, Kd1. As the ionic strength is increased
(µ=0.04-0.27), the Kd1 (NADPH) also increases (0.35-20µM) (Table 5). The slope of a loglog plot of Kd1 (NADPH) vs. ionic strength is 2.0 ± 0.3 (Figure 5). The slopes of these types
of plots have previously been taken to describe Z, the number of ionic interactions
involved in binding (22-24). Due to the high Kd1 associated with binding of DHF (125
µM), Kd (DHF) values could not be measured using this approach.

56

Table 4. Binding of NADPH to wt and K33M R67 DHFRs in MTA buffer (pH 8) as
measured by ITC.
DHFR
Kd1 (NADPH)
Species
(µM)
wt R67
5.0 ± 0.3
DHFRa
K33M DHFR 19 ± 0.3
a
Data from Bradrick et al., (3).

∆H1 (cal/mol)

∆H2 (cal/mol)

-8600 ± 200

Kd2 (NADPH)
(µM)
48 ± 2.0

-6500 ± 22

630 ± 29

-530 ± 55

-5800 ± 250
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Table 5. Determination of Kd1 (NADPH) in wt
R67 DHFR using a fluorescence quenching
approach (TE buffer, pH 7).
Ionic
Strength
(µ)
0.04

Kd (NADPH)
(µM)

0.05

0.65 ± 0.09

0.07

0.86 ± 0.01

0.09

1.5 ± 0.2

0.11

3.3 ± 0.5

0.15

7.5 ± 0.7

0.18

7.9 ± 0.8

0.21

14 ± 4

0.22

15 ± 0.7

0.27

20 ± 0.1

0.35 ± .01
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Figure 5. Log-log plot of Kd (NADPH) vs. ionic strength. The Kd as determined by
quenching of R67 DHFR fluorescence upon NADPH addition. Kd values are given in
Table 5. As the ionic strength is increased, the Kd (NADPH) increases.
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Isothermal Titration Calorimetry with NADPH
To gain additional information on the effects of ionic strength on NADPH
binding, ITC was also used. The shape of the titration curves varied, with a sigmoidal
plot observed at µ = 0.02 and a hyperbolic plot at µ =0.32. At high ionic strength, the
second molecule of NADPH either does not bind (i.e., cooperativity is altered) or binding
becomes sufficiently weak that we are unable to saturate this site. This suggested use of
a single site model for fitting, and at intermediate values of µ, fitting to this model gave
reasonable fits. (Also fitting to 2 sites consistently yielded one Kd equivalent to the
single site model). Values obtained from these titrations are shown in Table 6 and
Figure 6. Kd1 (NADPH) increases from 0.4 to 47 µM as µ increases from 0.02 to 0.3. The
slope of the log-log plots for Kd1 (NADPH) vs. ionic strength is 1.8 ± 0.08. In addition, the
total heat evolved (q Total) decreases with increasing ionic strength, consistent with loss of
ionic interactions. These results, in conjunction with the fluorescence quenching data
above, indicate two ionic interactions are involved in binding the first NADPH molecule.
Isothermal Titration Calorimetry with Folate
ITC was also used to monitor salt effects on folate binding. The poor substrate,
folate, was used in these experiments instead of DHF, since salt destabilizes DHF over
the time period required to run an ITC experiment. Folate is similar in structure to DHF
except that it possesses a double bond between C7 and N8. In these experiments, we are
unable to consistently fit the titrations for folate binding to two sites, suggesting the
occurrence of an additional process during binding. One possibility might involve some
effect associated with binding of folate dimers from solution. Dimerization of folate has
previously been reported (25). Even with this potential complication, we can
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Table 6. Isothermal titration calorimetry data describing
binding of NADPH to wt R67 DHFR in TE buffer (pH 7)
with NaCl added to adjust the ionic strength.
Ionic Strength
(µ)
0.02

Kd1 (NADPH)
(µM)
0.4 ± 0.04

∆H1 (cals/mol)

0.02

0.35 ± 0.03

-8814 ± 30

0.07

0.63 ± 0.02

-7781 ± 60

0.07

0.61 ± 0.2

-7986 ± 50

0.12

16 ± 0.07

-7806 ± 40

0.12

16.2 ± 0.06

-6870 ±38

0.15

14 ± 0.07

-7692 ± 50

0.15

14.6 ± 0.03

-7513 ±120

0.22

34.9 ± 0.06

-4992 ±130

0.22

37.7 ± 0.02

-6341 ± 50

0.27

47.5 ± 0.01

-4617 ± 80

0.27

46.6 ± 0.01

-4472 ± 70

-8949 ± 30
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Figure 6. Effects of increasing ionic strength on binding of NADPH to wt R67 DHFR as
monitored by ITC. Kd values were measured for the tight site, Kd1 (NADPH) as shown in
panel A. As the ionic strength increases, the Kd (NADPH) increases. The corresponding
qTotal values (total heat) decrease with increasing ionic strength, as shown in panel B.
Experiments were performed at ionic strengths of 0.02 (c), 0.07 ( ), 0.12 (S), 0.15
(V), 0.22 (), and 0.32 (z). Kd values are listed in Table 6.
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qualitatively note the effect of increasing ionic strength on folate binding by plots of total
enthalpy (q Total) vs. folate concentration. This plot reveals that the binding process is less
exothermic (i.e., involves lower enthalpy values) as the concentration of salt increases
(Figure 7). Increasing µ has a clear effect; however, we are unable to extract the number
of interactions disrupted.
Binding of folate to a 1:1 mixture of R67 DHFR:NADPH was also performed in
varying salt concentrations. One folate molecule binds to form the ternary complex, and
the Kd values in Table 7 show no evidence of a titration. However a titration is observed
when the ∆H values are evaluated. At low ionic strength, ∆H remains constant at
approximately -13,000 cal/mol. Only one intermediate point was monitored before a
second plateau in ∆H is observed (at approximately -5800 cal/mol). This titration
indicates folate binding is salt dependent in the ternary complex, and since the titration is
complete by a µ of 0.22, the ionic interaction must be weaker than those observed in
either the 2 NADPH or the 2 folate complexes.
Steady-State Kinetic Analysis in Presence of Salt
Salt effects on steady state kinetics were also performed with wt and K33M R67
DHFRs to investigate further the importance of ionic interactions in ligand binding and
catalysis. As the buffer is changed from MTA to TE, minor differences in Km are
noticed. More interestingly, as the ionic strength is increased, the binding of both
cofactor and substrate is weakened. In addition, the kcat values increase. Concentrations
of up to 0.4M NaCl were used to examine salt effects (Table 8).
To quantify the number of ionic interactions involved in ligand binding and
catalysis, log-log plots of the steady state kinetic data vs. ionic strength were generated.
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Figure 7. Effects of ionic strength on the total heat of folate binding as measured by
ITC. The protein concentration was 100 µM for all experiments. The total heat observed
upon folate addition is plotted at various ionic strengths (µ=0.15 (c), µ=0.22 ( ),
µ=0.27 (U), and µ=0.32 ()).
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Table 7. Isothermal titration calorimetry data for folate binding to a 1:1 mixture
of R67 DHFR:NADPH at 13°C in TE (pH 7) in the presence of various salt
concentrations to adjust the ionic strength. These data were fit to a single site
model using the Origin software.
Ionic Strength

Kd (µM)

n

∆H (cal/mol)

0.02

11.0 ± 0.4

0.95

-13100 ± 180

# of
Experiments
2

0.07

20.0 ± 1.0

1.0

-13300 ± 390

2

0.15

15.2 ± 0.4

1.0

-8300 ± 67

2

0.22

9.5 ± 0.7

0.98

-5700 ± 130

2

0.27

13.3 ± 0.8

0.99

-5800 ± 150

2

0.32

12.8 ± 0.8

1.1

-5700 ± 100

2
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Table 8. Steady-state kinetic values for wt and K33M R67 DHFRs
in TE (pH 7) in the presence of NaCl to adjust the ionic strength (µ).
Km (NADPH)
(µM)

Km DHF
(µM)

kcat
(s-1)

8.7 ± 0.4

13 ± 0.7

1.5 ± 0.04

0.2M
(µ=0.22)

13 ± 0.8

29 ± 1.8

2.0 ± 0.1

0.3M
(µ=0.32)

26 ± 1.3

54 ± 2.5

2.8 ± 0.1

0.4M
(µ=0.42)
K33M R67 DHFR
0.13M
(µ=0.15)

41 ± 2.3

81 ± 4.3

3.7 ± 0.2

33 ± 1.3

25 ± 1.3

2.3 ± 0.1

0.2M
(µ=0.22)

50 ± 3.0

32 ± 1.9

2.2 ± 0.01

0.25M
(µ=0.27)

68 ± 3.5

53 ± 2.2

3.3 ± 0.1

0.3M
(µ=0.32)

91 ± 5.5

88 ± 5.3

3.9 ± 0.2

0.35M
(µ=0.37)

170 ± 6.4

140 ± 4.5

5.5 ± 0.1

R67 DHFR Species
NaCl concentration
(ionic strength)
wt R67 DHFR
0.13M
(µ=0.15)
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These plots are shown in Figure 8 and their corresponding slopes are given in Table 9.
Surprisingly, there is a linear relationship between ionic strength and kcat for the R67
DHFR reaction. The slope of the log-log plot for the wt enzyme is 0.9 ± 0.08.
Additionally, slopes of 1.8 ± 0.2 and 1.5 ± 0.1 for the log-log plots of ionic strength vs.
Km (DHF) and Km (NADPH) are observed for wt R67 DHFR. Finally, since ionic strength
effects on kcat result in rate enhancements (slope effects of ~1), while salt effects on Km
are consistent with weaker binding (slope effects of ~2), the overall effect on kcat/Km is a
net decrease in catalytic efficiency (slope effects of approximately -1). These results, in
conjunction with the above binding studies, suggest a model where 2 salt sensitive
interactions are involved in initial ligand binding, however one of these interactions is
lost as the ground state proceeds towards the transition state.
A comparison of the salt effects on wt and K33M R67 DHFRs shows that the
slopes of the various plots are quite similar (Table 9). We conclude K33 is not the
residue responding to the presence of salt.
Effect of Different Salts on Binding
To evaluate if these salt effects on wt R67 DHFR are due to a non-specific and/or
or a salt specific effect resulting in disruption of an ionic interaction, kinetic
characterization was also performed in the presence of NaF as well as NaSCN (26-28).
The steady-state data are given in Tables 10 and 11 and are represented graphically in
Figure 9. The abbreviated Hofmeister series (SCN-, I-, Br-, Cl-, F-) indicates F- has a high
charge density and a high energy of hydration, making it least able to compete with a
charged ligand for binding. Cl-, in the middle of the Hofmeister series, has a neutral
effect, while SCN-, with a lower charge density and lower energy of hydration, is more
67

1

-1 -1
kcat/Km (DHF) (s µM )

100
10
0.1
1
Ionic strength

0.1

0.01
10

B

1

100
10
0.1
1
Ionic strength

0.1

0.01
10

-1
kcat (s )

Km (NADPH)

A

Km (DHF)

-1 -1
kcat/Km (NADPH) (s µM )

10

C

1
0.1

0.01
0.1

Ionic strength (µ)

1

Figure 8. Log-log plots of steady-state kinetic values vs. ionic strength for wt and K33M
R67 DHFRs. Kinetics were performed with wt (S, ∆) and K33M (z, Ο) R67 DHFRs in
the presence of increasing NaCl concentrations. Panels A and B show the effects on
kcat/Km with insets showing the effects on the respective Kms. Panel C shows the effect
of increasing salt on kcat. The values are given in Table 8 and the slopes are presented in
Table 9.
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Table 9. Slopes of the log-log plots for kcat/Km (NADPH), kcat/Km (DHF), kcat, and
Kms as a function of ionic strength for wt and K33M R67 DHFRs in the
presence of NaCl or NaF.
R67 DHFR
Species
(Salt)

slope of
kcat/Km

slope of
kcat/Km

(NADPH)

(DHF)

plot

slope of
kcat
plot

plot

slope of
Km
(NADPH)

slope of
Km (DHF)
plot

plot

wt R67 DHFR
(NaCl)

-0.6 ± 0.09 -0.9 ± 0.03 0.9 ± 0.08

1.5 ± 0.1

1.8 ± 0.2

wt R67 DHFR
(NaF)

-0.9 ± 0.2

-0.8 ± 0.08 0.9 ± 0.2

1.7 ± 0.4

1.6 ± 0.2

wt R67 DHFR
(NaSCN)

-1.6 ± 0.2

-1.5 ± 0.2

0.7 ± 0.3

2.2 ± 0.2

2.2 ± 0.2

K33M DHFR
(NaCl)

-0.7 ± 0.03 -0.9 ± 0.09 1.0 ± 0.3

1.7 ± 0.2

1.9 ± 0.4
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Table 10. Steady-state kinetic values for wt R67 DHFR in the presence of
increasing concentrations of NaF in TE, pH 7.
wt R67 DHFR
NaF concentration
(ionic strength)

Km (NADPH)
(µM)

Km (DHF)
(µM)

kcat
(s-1)

0.08M
(µ=0.12)

1.7 ± 0.02

4.6 ± 0.3

1.0 ± 0.01

0.13M
(µ=0.15)

6.4 ± 0.3

11 ± 0.5

1.8 ± 0.05

0.3M
(µ=0.32)

15 ± 0.9

30 ± 1.6

2.5 ± 0.1

0.6M
(µ=0.62)

42 ± 2.8

81 ± 6.2

4.7 ± 0.3
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Table 11. Salt effects on the kinetic parameters for wt R67 DHFR in
the presence of TE, pH 7 with various concentrations of NaSCN
added to adjust the ionic strength.
NaSCN
concentration
(ionic
strength)

Km (NADPH)
(µM)

Km (DHF)
(µM)

kcat
(s-1)

0.08
(µ=0.06)

4.9 ± 0.3

12.7 ± 0.2

1.3 ± 0.01

0.1
(µ=0.08)

7.8 ± 0.4

21.7 ± 0.9

1.2 ± 0.02

0.12
(µ=0.1)

12.3 ± 0.7

38.6 ± 1.9

1.8 ± 0.02

0.15
(µ=0.13)

24.5 ± 1.2

57.6 ± 2.6

2.4 ± 0.01

0.18
(µ=0.16)

28.3 ± 1.3

69.8 ± 2.8

1.9 ± 0.02
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Figure 9. Steady-state kinetics performed with wt R67 DHFR in NaF () compared to
the kinetic values obtained in the presence of NaCl (z) and NaSCN (S). The plots of log
kcat/Km vs. log ionic strength reveal that the effect of salt on the slope is the same for
NaCl and NaF but NaSCN affects the slope differently (panels A and B). The kinetic
values are given in Tables 8, 10, and 11 and the slopes are in Table 9.

72

able to compete for binding (26-29). Thus, the use of different salts allows specific
anion effects to be discerned from ionic strength effects. While the absolute values for
kcat and Km are somewhat different, comparison of the slopes for the NaCl and NaF plots
yields values within error of each other, suggesting there is not a significant difference
depending on anion type (Table 9). However extending the comparison to NaSCN shows
a different slope for kcat/Km values, suggesting the presence of specific anion effects.
NADPH versus NADH Binding
To probe whether the 2’ phosphate off the adenine ribose of NADPH is involved
in one of the ionic interactions with wt R67 DHFR, the alternate cofactor NADH was
used in steady state kinetic analysis. DHF inhibition is noted, particularly at low ionic
strengths, perhaps arising from weaker binding of NADH and less positive cooperativity
between NADH and DHF, which allows more ready formation of the inhibitory 2DHF
complex. Since fitting data sets displaying inhibition using SAS requires some
knowledge of the various Kds involved (16), we are not certain that the output is as
accurate as our kinetic data generated in the absence of inhibition. A qualitative
observation is that the rate clearly increases with increasing salt concentration, as do the
Km values (Figure 10 and Tables 12 and 13). That the rate increases using either NADPH
or NADH as cofactor while ionic strength concurrently increases suggests the ionic
interaction broken going from the ground state to transition state involves the PPi bridge,
since this is the common negatively charged moiety.
There is no obvious DHF inhibition observed when NADH is used at µ=0.32 and
the steady state kinetic data can be fit easier. Table 14 shows the Km for NADH is 12
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Figure 10. Salt effects on NADH binding to wt R67 DHFR. In the presence of TE, pH 7
with various concentrations of NaCl to adjust the ionic strength, NADH binding is salt
sensitive in the ground state (insets in panels A and B) compared to the transition state
(panels A and B). Kinetic values are illustrated in Tables 12 and 14 and slopes are given
in Table 13.

74

Table 12. Steady-state kinetics describing NADH binding to wt R67
DHFR in TE (pH 7) buffer in the presence of various amounts of
NaCl to adjust the ionic strength.
kcat (s-1)

Ionic Strength
(µ)
0.08
(µ=0.1)

Km (NADH)
(µM)
57 ± 1.6

Km (DHF)
(mM)
68 ± 1.7

0.22 ± 0.01

0.13
(µ=0.15)

80 ± 3.4

162 ± 20

0.5 ± 0.03

0.18
(µ=0.2)

94 ± 3.6

220 ± 19

0.48 ± 0.02

0.30
(µ=0.32)

320 ± 17

250 ± 16

0.7 ± 0.04
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Table 13. Slopes of log-log plots of kinetic parameters vs. ionic strength for wt R67
DHFR in the presence of NADPH and NADH.
wt R67 DHFR

slope of
kcat/Km

slope of
kcat/Km

(NADPH)

(DHF)

slope of
kcat
plot

NADPH

0.6 ± 0.09

0.9 ± 0.03

NADH

0.3 ± 0.4

0.2 ± 0.03

plot

(NADPH)

slope of
Km (DHF)
plot

0.9 ± 0.08

1.5 ± 0.1

1.8 ± 0.2

1.0 ± 0.3

1.3 ± 0.3

1.4 ± 0.3

plot

slope of
Km
plot
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Table 14. Steady-state kinetic values for wt R67 DHFR with
NADH in the presence of 0.3M NaCl TE, pH 7.
Km (cofactor)
wt R67 DHFR
Km (DHF)
kcat
cofactor
(s-1)
(µM)
(µM)
(ionic strength)
NADH
(µ=0.32)

320 ± 17

250 ± 16

0.7 ± 0.04

NADPH
(µ=0.32)

26 ± 1.3

54 ± 2.5

2.8 ± 0.1
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fold higher than that for NADPH and the kcat value is decreased 4 fold. This combines to
increase kcat/Km (cofactor) 50 fold. The Km for DHF is also affected, being 4.6 fold higher.
Measurements of Km values for NADH were not made beyond an ionic strength of 0.32
due to limitations in the range of the spectrophotometer. An increase in Km (NADH)
compared to Km (NADPH) for R67 DHFR has previously been observed by Smith and
Burchall (30). Similar fold effects have also been seen in E. coli DHFR where R44L and
H45Q mutations were constructed to evaluate the role of these residues in binding the
2’phosphate and PPi moieties of NADPH (31). The R44L and H45Q mutations altered
the Kd for NADPH (monitored by fluorescence quenching) by 11 and 6 fold respectively,
while binding of dihydrofolate was unaltered. Effects on the hydride transfer step were
21 and 3 fold decreases respectively. Together, these data illustrate the importance of the
2’phosphate moiety in different DHFR scaffolds by the large effects on binding in the
absence of this group.
Discussion
The role of ionic interactions in binding and catalysis in R67 DHFR has been
investigated. The following observations indicate that ionic interactions play a role in
these processes. 1) Fluorescence quenching and ITC data reveal that Kd1 (NADPH) increases
with increasing ionic strength. 2) ITC experiments show qTotal associated with NADPH
binding becomes less negative as ionic strength increases. 3) ITC data demonstrate
binding of 2 folate molecules is a salt sensitive process. 4) Calorimetry experiments
show a titration in ∆H for folate binding to R67 DHFR•NADPH that is complete by a µ
of 0.22. 5) Salt effects are observed by monitoring the steady state kinetic behavior of
the wt enzyme in buffers of increasing ionic strength. Higher Kms for NADPH and DHF
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are observed as salt concentration increases as well as an enhancement of kcat. 6) Similar
salt induced slope effects are observed for the wt and K33M enzymes. The only charged
residues near the active site in this mutant are the symmetry related K32 residues. 7) Our
mutagenesis studies implicate only a minor role for K33 in binding illustrated by the 2-4
fold weaker Km values for the K33M mutant. The fold changes associated with the
K33M mutant are smaller than the observed salt effects. 8) There is a 50 fold effect on
kcat/Km (cofactor) in the presence of NADH at µ= 0.32, suggesting the 2’ phosphate is
involved in an ionic interaction with R67 DHFR. 9) pH titration studies reveal that
increasing the concentration of NaCl up to 0.75M does not affect the stability of the
enzyme.
Quantitation of the Number of Ionic Interactions Involved in Ligand Binding
Quantitating the number of ionic interactions involved in ligand binding was first
described by Record et al., in 1976 using various proteins binding to DNA (22).
Recently, Park and Raines (23) have described the requirements for quantitating the
number of ionic interactions involved in ligand binding and catalysis using salt-rate
profiles. One of the conditions is that an increase in the concentration of salt does not
cause a decrease in the stability of the enzyme. pH titration studies with wt R67 DHFR
reveal that increasing the NaCl concentration up to 0.75M does not significantly affect
the conformation of this enzyme. In addition, to be able to use salt effects to
quantitatively monitor ionic interactions, the kcat should reflect the chemical step, not
product release (23). Hydride transfer is the rate-determining step in the R67 DHFR
reaction as monitored by NADPD isotope effects (32). Another preference is for the
assays to be monitored at the pH optimum to minimize any pH effects. This criterion
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was not met with respect to R67 DHFR, as activity increases as the concentration of
protonated DHF increases (N5 pKa of 2.59) (23, 33). This titration is masked however as
the active site pore in the wt homotetramer is lost upon dissociation into dimers (Figure
2A). While this criterion was not met, the assay pH was carefully maintained at pH 7.0
and any systematic alterations in pH should be minimal and would not be expected to
propagate into large (unitary) slope effects. Finally, variance of the anion character
should minimally affect the slope of the resulting plots. While the slopes describing
steady state kinetic parameters of R67 DHFR are similar in NaCl and NaF, higher slopes
for kcat/Km are observed in NaSCN. A different effect by SCN- suggests the additional
presence of specific anion effects. A recent study of lysozyme crystal structures obtained
in different salts (NaI, NaNO3, KSCN and p-toluene sulfonate) shows the presence of
common anion sites as well as specific sites (34). Binding strategies include contacts
with Arg and Lys sidechains as well as H-bonds with other residues (either side- or mainchain). Thus while specific anion sites apparently occur in R67 DHFR, the likelihood of
common anion sites remains reasonable. Another instance of general ionic strength
effects augmented by specific anion effects has also been noted by Lee et al. in measuring
different salt effects on the pKas of histidines in Staphylococcal nuclease (35).
How Many Ionic Interactions are Involved in Ligand Binding
Log-log plots of Kd (NADPH) vs. ionic strength, from both fluorescence quenching
and ITC studies, display slopes of ~2. These combined results suggest two ionic
interactions are likely to be involved in binding each NADPH molecule in the presence of
NaCl. This is also observed by a 50-fold decrease in catalytic efficiency using NADH as
a cofactor (involvement of 2’phosphate) as well as a salt effect on kcat using NADH.
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We have been unable to obtain Kd values for DHF/folate by either fluorescence
quenching or ITC under various salt conditions. However folate binding under binary
complex conditions is salt sensitive as shown in Figure 7. In contrast, folate addition to
the R67 DHFR•NADPH complex shows no change in Kd values coupled to a titration in
enthalpy that is complete by a µ of 0.22. These results suggest different salt sensitivities
for the R67 DHFR•2 folate and R67 DHFR•NADPH•folate complexes.
The observation that the Kd for folate binding to the ternary complex does not
vary while a titration in ∆H is observed invokes enthalpy-entropy compensation (36-39).
In this process, the unvarying Kd describes ∆G as ∆G = -RT ln Ka where Ka is the
association constant and equals 1/Kd. For a titration in ∆H to occur, coupled with a
constant ∆G value, suggests a compensating change in entropy (from the relationship ∆G
= ∆H - T∆S). These results suggest a catalytic strategy to minimize effects on the
productive ternary complex as compared to the non-productive complexes. Specifically,
binding of folate at low salt involves at least one ionic interaction, which is lost by µ =
0.22. Loss of the ionic interaction could readily be compensated for by a decreased
desolvation penalty. In other words, ions are strongly solvated and to form an ion pair,
both ions must be desolvated; this process opposes ion pair formation (40).
Why Does kcat Increase with Increasing Ionic Strength?
In the kinetic studies with wt and K33M R67 DHFRs, an increase in kcat is
observed with increasing ionic strength. This observation is unusual as Park and Raines
(23) note that in most enzymes, the ground state resembles the transition state and
changes in ionic interactions typically do not occur. However these observations are not
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totally unprecedented as increases in kcat have been observed with the NADPHcytochrome oxidoreductase-cytochrome c complex (41) as well as the herpes simplex
virus protease in the presence of increasing ionic strength (42). The slope of the log-log
plot of kcat vs. ionic strength (NaCl) in wt R67 DHFR is approximately one. The
increased rate could potentially arise if salt increased the N5 pKa of DHF since
protonated DHF is the productive substrate for R67 DHFR (32). However Cocco et al.,
(43) find this pKa is not significantly altered by increased ionic strength. Therefore, an
increase in the concentration of protonated DHF is probably not responsible for the
increase in kcat. A second possibility for the increase in kcat might be due to a larger
destabilization of the ground state relative to the transition state as µ increases. This
would result in a decrease in the activation energy barrier to reach the transition state and
an increased kcat. This argument is supported by a slope of 2 for the log-log plots of Kd
(NADPH) vs.

ionic strength contrasted with a subsequent decrease in the slope to 0.6-0.7 for

the log-log plots of kcat/Km (NADPH) vs. ionic strength. The data in Figure 8C indicate that
transition state binding is different than ground state binding and that 1 salt bridge is
broken as the ground state moves to the transition state.
Which Residues in R67 DHFR are Involved in Ionic Interactions with the Ligands?
There are several possible binding models that would allow two ionic interactions
between R67 DHFR and NADPH. The first model involves one K32 residue and one
K33 residue binding to different ionic centers in NADPH. However, from the crystal
structure, K32 appears on the binding surface of the active site pore making it more likely
to be involved in a direct interaction than K33 (2). In addition, our docking studies
indicate symmetry related K32 residues are involved in binding both NADPH and DHF,
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while no direct interactions are predicted for K33 (4). Further, the salt effect observed
for the K33M mutant is similar to the salt effect observed in wt R67 DHFR. In the
K33M mutant, symmetry related K32 residues are the only positively charged residues
remaining near the active site pore that possess the potential to be involved in ionic
interactions with the substrates. Thus, this model can be eliminated. A second model
involves two K32 residues, each from a different monomer of R67 DHFR, contributing
separate ionic interactions. K32 (monomer A) could interact with the 2’phosphate while
K32 (monomer C) would interact with the pyrophosphate bridge (Figure 1). This model
appears reasonable and is similar to a docked model of NADPH ((4) and unpublished
results).
A model for folate/DHF binding is less clear. From examination of the crystal
structure, the two carboxylate groups from the Glu tail of DHF cannot span across the
end of the pore to interact with two K32 residues from different monomers in R67
DHFR. This limitation suggests only one ionic interaction can occur per bound
DHF/folate. We were unable to support this model by quantitating the number of
interactions involved in formation of the 2 folate complex. Also, the ITC data for folate
addition to R67 DHFR•NADPH did not quantitate the number of interactions, but this
interaction must be relatively weak as the ∆H titration is complete by µ=0.22. Previous
studies supporting mobility for the Glu tail, include electron density for only the pteridine
rings in the crystal structure describing bound folate (2), interligand NOE data for the glu
tail in the R67 DHFR•NADP+•folate complex (44) and numerous positions for the
PABA-Glu tail of folate in docking studies to generate a reasonable model of the ternary
complex (4).
83

Which Regions of NADPH are Involved in Forming Ionic Contacts with R67 DHFR?
K32 is conserved in all R-plasmid encoded variants, suggesting it has a functional
and/or structural role (5). It has been proposed that K32 interacts with the 2’phosphate of
NADPH ((4) and Narayana, personal communication). Kinetic studies using NADH as
an alternate cofactor reveal a much weaker Km for NADH compared to NADPH at an
ionic strength of 0.32. Since these molecules are identical in structure except for the
substitution of a negatively charged phosphate at the 2’ position with a hydrogen, the
observed effects on the NADH vs. NADPH Km values are consistent with the 2’
phosphate forming an ionic interaction with wt R67 DHFR. NMR studies (Bob London,
manuscript submitted) are also consistent with an ionic interaction between K32 and the
2’phosphate of NADPH. Yet, two ionic interactions are predicted from the log-log plots
of Kd (NADPH) and Km (NADPH) vs. ionic strength. Therefore, there must be an additional
ionic interaction between the pyrophosphate bridge of NADPH and the enzyme. This is
supported by our qualitative observation that the rate increases with increasing salt
concentration when NADH is used as cofactor. That a rate increase occurs using either
NADPH or NADH as cofactor suggests the ionic interaction broken going from the
ground state to the transition state involves the PPi bridge.
While the above model is consistent when all the NaCl data are taken into
account, the observation that NaSCN slope effects on kcat/Km are different indicate some
degree of anion specificity and suggest the above arguments must remain qualitative.
While an Ocam’s razor approach supports a simple pattern of binding and catalysis that is
consistent with the above model, we cannot rule out more unusual effects arising from
specific ion interactions, as well as the effect of salts on desolvation penalties, the extent
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of accumulation or exclusion of the solute from the protein surface, the result of charges
propagating through a hydrophobic interior, long range electrostatic interactions or the
effect of salt on water properties (34, 35, 45-47).
What is the Role of K33?
K33 is also conserved in all R-plasmid encoded variants, which suggests that it
has a functional role as well. However, its role in binding is not as clear. The similar
slopes for salt effects on the wt and K33M mutant enzymes indicate no direct ionic
interaction between this residue and the ligands. Yet, ITC reveals this mutant plays a
minor role in the negative cooperativity during binding of two NADPH molecules. It
may be involved in properly positioning K32. Alternatively, K33, along with K32, may
enhance the positive electrostatic potential at the active site pore of R67 DHFR to aid in
binding (4, 48).
It is interesting to note that the contiguous R31 residue is also conserved, as is
E75, the sidechain of which is in van der Waals contact with R31. R29 and E60 are also
nearby, conserved and in close contact. A recent report notes that clusters of positively
charged residues are rare, and may be important in protein structure and function (49).
Perhaps this charge grouping facilitates NADPH and folate binding.
Summary and Conclusions
DELPHI, a finite Poisson-Boltzmann difference solver, predicts that K32 and K33
generate a positive electrostatic potential at the active site pore of R67 DHFR (4).
Numerous enzymes have been proposed to utilize an electrostatic potential to guide
ligands into the active site where specific interactions can then occur for binding of
substrate (50-52). A model for the role of electrostatics in ligand binding and catalysis in
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R67 DHFR suggests K32 and K33 guide the negatively charged ligands to the active site
pore by establishing a positive electrostatic potential. Once the ligands are proximal to
the active site, symmetry related K32 residues likely contribute direct ionic interactions
with NADPH and likely DHF (at very low salt). After formation of the ground state
complex, at least one ionic interaction breaks, leading to hydride transfer. This key event
probably involves loss of an ionic interaction between the enzyme and the pyrophosphate
bridge of NADPH. This scenario could permit the ligands to move towards the
“hourglass” center of the pore, facilitate stacking between the pteridine and nicotinamide
rings as well as exclude solvent, and ultimately lead to the correct distance and angle for
hydride transfer. This unusual mechanism could arise from the need to balance catalysis
with the constraints of the structure, e.g. the 222 symmetry of the active site pore. For
example, if 2 ionic interactions occur between NADPH and symmetry related K32
residues, then while loss of one interaction (by a mutation) could enhance kcat, the
concurrent loss of the second symmetry associated interaction would necessarily decrease
catalytic efficiency (kcat/Km). Introduction of asymmetry into the active site pore should
help sort out these various models of catalysis and perhaps lead to enhanced activity.
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Part III: Probing the Role of K32 Using Asymmetric Mutations in R67
Dihydrofolate Reductase
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Abstract
Salt effects on the kinetic behavior of wt R67 DHFR have aided in the understanding of
the catalytic strategy of R67 DHFR. However, it left one major question unanswered.
What residue(s) in R67 DHFR participate in ionic contacts with the carboxyl groups in
the para-aminobenzoic acid tail of DHF (PABA-glu) as well as the oxygen atoms of the
pyrophosphate bridge and 2' phosphate off the AMP ribose ring of NADPH? Several
studies predict that K32 residues are involved; however, destabilization of the R67 DHFR
homotetramer upon mutation of symmetry related K32 residues, hindered examination of
this hypothesis directly. Therefore, the goal of this research is to investigate the
involvement of K32 in the catalytic mechanism of R67 DHFR using K32M asymmetric
mutants. These mutants were generated by linking four gene copies in frame, each of
which encode a monomer of R67 DHFR (1). To identify which K32 residues participate
in binding and/or catalysis, salt effect studies were performed with the K32M asymmetric
mutants and compared to wt R67 DHFR. From these studies, it seems the symmetry of
the R67 DHFR active site plays a major role in ground state binding. Specifically,
limiting the number of K32 residues available for participating in ionic interactions, as
with the K32M: 1+2 and K32M: 1+4 mutants, reduces kcat. In addition, studies with the
K32M: 1+3 mutant indicate that formation of the transition state is facilitated by the loss
of an ionic interaction(s) with DHF. The K32M: 1+3 mutant possesses two K32
mutations in one half pore, thus the ability of K32 to participate in an ionic interaction(s)
with DHF has been eliminated. Hence, the increase in kcat for this mutant compared to
Quad3, supports that formation of the transition state is facilitated by the loss of an ionic
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interaction. From these studies, several models can be generated to describe a role for
ionic interactions in the ground state compared to the transition state.
Introduction
R67 dihydrofolate reductase (R67 DHFR) confers resistance to the antibiotic
trimethoprim (TMP) to its host E.coli. Thus, this enzyme is clinically important as it
allows E.coli to sustain life even though the chromosomally encoded DHFR enzyme is
inhibited by this antibiotic. R67 DHFR provides resistance because of its sequence and
structural uniqueness. Therefore, this is an interesting system to study in order to
understand the mechanism through which it avoids inhibition. One of the first research
questions addressed to more fully understand the catalytic mechanism of R67 DHFR was
the importance of ionic interactions in ligand binding and catalysis. While the data from
this research support a role for ionic interactions in R67 DHFR, a major question
remains. Which residues in R67 DHFR are involved in ionic interactions with the
negatively charged moieties of the substrate and cofactor? Specifically, these contacts
include the carboxylate groups of the para-aminobenzoic acid tail (PABA-glu) of DHF
and the 2'phosphate off the AMP ribose as well as the pyrophosphate bridge of NADPH.
R67 DHFR possesses an active site made up of four identical monomers.
However, relatively few residues are involved in formation of the active site and thereby
participate in catalysis (2). Only four charged residues are located in the active site.
These are symmetry related K32 residues, one of which is located in each monomer.
NMR and docking studies suggest that one role of K32 is an ionic interaction between the
Nε of K32 and the 2’phosphate off the ribose of the AMP moiety of NADPH. Briefly, in
addition to K32 being the only charged residue in the active site, a chemical shift in the
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resonances associated with the sidechain of K32 was observed upon NADPH binding.
Also, docking of NADPH into the R67 DHFR•folate complex predicts that K32 is in
proximity of the 2’phosphate of NADPH, thus allowing an ionic interaction (3, 4).
Docking studies have also predicted that the Nε of K32 in an adjacent monomer may
interact with the γ-carboxyl group on the glutamate tail of DHF (3). Another proposed
role of K32 is generation of a positive electrostatic potential at the active site pore as
predicted by the Poisson-Boltzmann difference solver, DELPHI. K33, located on the
surface of the enzyme with its side chain pointing out towards solvent, is also predicted to
be involved in generating the positive electrostatic potential (3). Positive electrostatic
potentials have also been predicted to occur not only in other DHFRs, including in
L. casei and humans (5), but also in acetylcholine esterase, and superoxide dismutase to
name a few (6, 7). Electrostatic potentials have been demonstrated to be important for
attracting ligands to the active site where specific binding interactions can then occur to
facilitate catalysis (5, 6).
Although our salt effect studies suggest that K32 is involved in ionic interactions
with both substrate and cofactor, a direct test of this hypothesis was unattainable in the
native R67 DHFR system as mutagenesis of K32 results in an inactive, dimeric form of
the enzyme (Hamilton, masters thesis) (8). To allow direct examination of the role of this
residue in binding and catalysis, we utilized a protein that was generated by linking in
frame four gene copies that code for the 78 amino acid monomer of R67 DHFR
(Figure 1). This protein product is active and has a mass four times the molecular mass
of the monomer. Hence, each monomer in R67 DHFR corresponds to a domain in this
protein. The linker sequence connecting the gene copies corresponds to the natural N95

Figure 1. DNA sequence of the four-gene copy construct of R67 DHFR linked in frame.
Quad1 is the gene sequence of the construct without unique restriction sites. Quad2 is the
construct containing unique restriction enzyme sites. Quad3 contains both unique
restriction enzyme sites and an S59A mutation in gene copy1 as well as an H62L
mutation in gene copy 4 to prevent topology changes. Asymmetric K32M mutants were
generated using the Quad3 construct.
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terminus. This construct is referred to as Quad1 (9). Later, four gene copies were again
linked in frame, but this time unique restriction sites were introduced between each gene
copy (1). This construct is called Quad2 (Figure 1). These restriction sites allow for
mutagenesis of individual gene copies to create an R67 DHFR mutant protein with
asymmetric mutations. Thus, the number of mutations as well as the domain in which the
mutations occur can be controlled using this system. This is advantageous since the
effects of a single, double, or even triple mutant can be evaluated to reveal specificity.
One initial concern of the quadruplicated system was the ability for changes in topology
to occur. In the linked protein, the carboxyl terminus of domain B is equidistant from the
amino terminus of domains C and D (Figure 2). This allows for the possibility of domain
flipping between domains C and D. Topology changes could thus result in domain B
being adjacent to domain C or domain D. In this case it would be impossible to
distinguish for example, K32M: 1+3 and K32M: 1+4 topologies since K32M: 1+3
contains a K32M mutation in domain C while K32M: 1+4 contains a K32M mutation in
domain D. Thus, assessing effects of mutations in these domains would be difficult due
to averaging of kinetic effects resulting from possible orientations. To prevent domain
flipping, an H362L mutation (gene copy 4) and an S59A mutation (gene copy 1) have
been introduced into Quad2 to constrain the topology of the tethered R67 DHFR protein.
This protein is called Quad3 (1) (Figures 1 and 2). This strategy was based on previous
experiments illustrating that a 1:1 mixture of S59 mutants (result in the formation of
inactive dimers) and H62L mutants (also result in inactive dimers) results in the
formation of an active hetero-tetramer of R67 DHFR (10). Mutagenesis of these residues
makes it unfavorable for topology switching to occur, as it would result in the pairing of a
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S59 ** H62
H62 ** S59

III

3

III

H62L
4
H62 **
1 S59A
** S59

S59 // H62L
2 H62
** S59 4

III

1

III

S59A // H62
H62 ** S59

3

Figure 2. Possible topologies of Quad3. S59A and H62L mutations in domains 1 and 4
prevent topology changes in the quadruplicated R67 DHFR protein. If domain flipping
occurs, S59 in domain 2 would interact with the hydrophobic H62L residue in domain 4
and S59A in domain 1 would interact with the polar H62 residue in domain 3.
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hydrophobic alanine residue (S59A) with a polar histidine (H62) as well as the paring of
a hydrophobic leucine (H362L) with a polar serine (S59) (1) (Figure 2). Using this
quadruplicated R67 DHFR gene system, K32M double mutants have been constructed
and the role of asymmetric K32 residues in ionic interactions with NADPH and DHF has
been assessed.
The symmetry of the R67 DHFR active site was utilized to construct asymmetric
K32M mutants. Mutations in gene copies 2 and 4 should be equivalent to mutations in
gene copies 1 and 3 just as mutations in gene copies 2 and 3 are equivalent to mutations
in gene copies 1 and 4. Due to this equivalence and for comparative purposes, the K32M
mutants will be named such that gene copy 1 is a reference. Hence, the asymmetric
double K32 mutants will be referred to as K32M: 1+2, K32M: 1+3, and K32M: 1+4. To
minimize confusion, we have adopted the following nomenclature. The Quad3 construct
containing a single K32M mutation in the second gene copy is referred to as K32M: 1.
K32M: 1+2 contains mutations in gene copies 1 and 2. These mutations are located at
positions corresponding to the monomer-monomer interface in wt R67 DHFR. K32M:
1+3 contains two K32M mutations located in domains 2 and 4, which reside in the same
half of the pore across from one another. K32M: 1+4 contains mutations in domains 2
and 3, which reside along the dimer-dimer interface. Two different diagrams showing
the various asymmetric mutations are illustrated in Figures 3 and 4. Due to structural
problems resulting from the K32M substitution in the homotetramer, precautions were
taken in generating the K32M: 1+4 mutant, which possesses two mutations at the same
interface. Since the symmetry of the active site of R67 DHFR dictates that all double
mutants should be equivalent, mutations in gene copies 2 and 3 should be equivalent to
100

Figure 3. The location of asymmetric K32M mutations depicted in the ribbon structure
of wt R67 DHFR. Each monomer in wt R67 DHFR corresponds to a domain in Quad3.
Domain 1 is colored red, domain 2 is yellow, domain 3 is green, and domain 4 is purple.
The expected positions of the mutations are shown in white whereas wild-type K32
residues are indicated in color. Figures on the left hand side show the homotetramer
looking end on with the active site pore in the center. Figures on the right hand side are
related to the figures on the left by a 90° rotation along the y-axis. (A). Ribbon diagram
illustrating the positions of K32 in each domain in CPK. (B). The K32M: 1+2 mutant
possesses mutations that are across the pore from one another located at the monomermonomer interface (red and yellow). (C). The K32M1+3 mutant contains mutations
located on the same side of the pore located above and below the monomer-monomer
interface (red and purple). (D). The K32M 1+4 mutant possesses mutations along the
dimer-dimer interface (red and green).
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Figure 4. Location of wt K32 residues in the active site of R67 DHFR. The wt K32
residues are depicted in red in reference to the sphere cluster representation of the active
site. The NADPH position in the active site is predicted from docking studies (3) and is
depicted in green. The top scoring folate conformer from docking studies (3) is depicted
in yellow. (A) Panel A illustrates the location of the four K32 residues in the active site.
(B) Panel B illustrates the location of the wt K32 residues in red in the K32M: 1+2
mutant. (C) Panel C depicts the positions of the wt K32 residues in the K32M: 1+3
mutant. (D) Panel D shows the location of wt K32 residues in the K32M: 1+4 mutant.
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mutations in gene copies 1 and 4. With this in mind, K32M: 1+4 was generated by
mutating gene copies 2 and 3. These domains were chosen since they are tethered by a
linker sequence, as opposed to gene copies 1 and 4, which are not linked. Therefore,
large structural perturbations should be minimized in this construct.
The focus of this research is to examine the role of K32 in both ground state and
transition state binding in R67 DHFR. Kinetic characterization of three K32 asymmetric
double mutants has been performed. In addition, the salt sensitivity of each of the
various kinetic parameters has been assessed. From these studies, a model for the role of
K32 in binding and catalysis has been proposed.
Materials and Methods
Construction of Quad3 and Asymmetric Mutants
To generate Quad3, four plasmids containing a single copy of the R67 DHFR
gene coding for monomeric R67 DHFR, each flanked by unique restriction enzyme sites,
were created. These genes were then ligated together. For example, one plasmid
containing the R67 DHFR gene possesses Bcl1 and EcoRV sites while another plasmid
contains the R67 DHFR gene flanked by EcoRV and KpnI. In order to generate an
asymmetric mutation, site-directed mutagenesis is performed using one plasmid
containing a single copy of the R67 DHFR gene. This mutated plasmid, as well as
Quad3, is then digested with the appropriate restriction enzymes. Digested DNA is
separated electrophoretically and the mutated DNA is ligated into the Quad3 construct in
place of the non-mutated wt R67 DHFR gene sequence (1). The oligonucleotide primer
for the coding strand used to generate mutations in different gene copies of Quad3
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corresponding to amino acid position 32 using the Stratagene QuikChange Mutagenesis
Kit was:
5’GGGTGACCGCGTACGTATGAAATCCGGAGCCGCC3’ (K32M)
All mutants were verified by automated fluorescence DNA sequencing at the University
of Tennessee DNA Sequencing Facility using an ABIPRISM Dye Terminator Cycle
Sequencing Kit from Perkin-Elmer.
Growth and Purification
E.coli STBLII cells containing the plasmid carrying the desired mutations were
grown in TB media (11) at 30°C for 60 hours in the presence of 200ug/ml AMP only
since introduction of TMP into the growth media results in random mutations within the
genes sequence. STBLII cells were used since they are a Rec A- strain and therefore
cannot undergo recombination. An aliquot of each of the 12 liters of the
K32M: 1+3 and K32M: 1+4 mutants were minipreped and sent for DNA sequencing to
verify the stability of these mutants over the 60 hour growth period. Cells were lysed
using sonication and the crude extract was precipitated with 55% ammonium sulfate.
Mutant protein was purified using a series of chromatographic steps including: DEAEFractogel and High-Q anion exchange columns as well as a G-75 Superdex size exclusion
column. During the purification process, the proteins were maintained in buffer solutions
containing 0.1g/L polyethylene glycol (PEG) since this addition minimizes aggregation
and leads to higher protein yields. Other reagents were also assayed for their ability to
reduce aggregation of the mutant proteins including ethanol, Brij, and glycerol.
However, this concentration of PEG seemed to be the most effective at minimizing
aggregation.
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pH titrations
To evaluate the effects of salt on the stability of Quad3, pH titrations were
performed in the presence of various concentrations of NaCl. These experiments monitor
the environment of W38 residues, which reside at the dimer-dimer interface. At pH 8,
these residues are buried and exhibit a different fluorescence property than when they are
exposed to solvent at pH 5 (12). The change in environment of the tryptophan residues is
linked to the protonation of H62 residues present at the dimer-dimer interface. As the
H62 residues become protonated, there is a loss of the tetrameric form of wt R67 DHFR
(13). While Quad3 cannot dissociate due to the linker sequences between each gene
copy, it can undergo a transition from a "closed" form (active conformation) to an "open"
form (inactive), which can be monitored using this technique. The averaged emission
wavelength <λ>, for each emission spectrum was calculated using
<λ>=Σ (Iiλi)/Σ(Ii)

(1)

where I is intensity, and λ is the wavelength (14). The fluorescence data were fit to using
a nonlinear regression subroutine of the Statistical Analysis Systems package (SAS,
Cary, NC) to obtain pKa values for each salt concentration tested. Fitting to the following
equation normalized the data:
Fapp=(Yobs – YpH8)/(YpH4 – YpH8)

(2)

where Fapp is a fractional value between 0 and 1, and Yobs, YpH8, and YpH4 are the optical
values associated with the observed pH and the pH limits 8 and 4, respectively.
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Circular Dichroism
Circular dichroism (CD) spectra were recorded at 22°C in 10 mM potassium
phosphate buffer, pH 5 and 8 with 10 µM wild type Quad3, K32M: 1+2, K32M: 1+3, and
K32M: 1+4 mutant R67 DHFRs using an Aviv Model 202 series circular dichroism
spectrometer. Data were collected from 190 nm to 300 nm using a cuvette pathlength of
1.0 mm. Spectra were generated for each sample using 2 nm steps with an integration
time of 2 seconds. A buffer baseline was subtracted from each scan and data were
subsequently converted to molar ellipticity (θ) using 108 g/mole as the mean residue
molecular weight.
Steady-State Kinetics with Mutants
Steady-state kinetics of each mutant were monitored using a Perkin-Elmer λ3a
spectrophotometer interfaced to an IBM PS2 computer using the software program UVS
(15). Experiments were performed at 30°C in either MTH buffer or TE buffer in the
presence of various concentrations of NaCl to adjust the ionic strength, at pH 7. Ligands
were diluted in TE buffer (without NaCl) for each experiment to minimize degradation,
particularly DHF. Five subsaturating concentrations of NADPH and DHF were used to
measure activity. Data were fit using the non-linear SAS program version 8.2, describing
the bi-substrate kinetic reaction of R67 DHFR (1). The extinction coefficient for the R67
DHFR reaction at 340 nm is 12,300 L mol-1cm-1 (16). Ligand concentrations used for
fitting were calculated using the extinction coefficient of 28,000 mol-1 cm-1 at 282 nm for
DHF (17) and 6220 L mol-1cm-1 at 340 nm for NADPH (18). Kinetics with the
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K32M: 1+3 mutant were obtained at 360 nm to more accurately assess the Km values.
The extinction coefficient for the DHFR reaction is 5020 L mol-1cm-1 at this wavelength.
Extinction coefficients for NADPH and DHF are 4020 L mol-1cm-1 and 2630 L mol-1cm-1
at 360 nm.
Results
Structural Effects of Salt Concentration
pH titrations with Quad3
pH titrations were performed with Quad3 in MTH buffer with 0M, 0.15M, 0.5M,
and 0.75M NaCl (Figure 5). The data were fit and the corresponding pKa values are
indicated in Table 1. It is apparent from the fits that addition of salt slightly stabilizes the
protein. However, there is not a significant difference in the titrations with Quad3 in the
presence of different salt concentrations around pH 7, where the majority of experiments
are performed.
Structural Effects of Mutations
Circular Dichroism of K32M Double Mutants
Circular dichroism spectra were generated for each of the K32M double mutants
at pHs 8 and 5. Comparison of the spectra for each mutant to that of Quad3 reveals that
the K32M: 1+2 and K32M: 1+3 substitutions do not result in a significant change in the
secondary structural content of the mutant proteins (Figure 6). Therefore, kinetic changes
observed with these mutants most likely do not result from a large conformational change
at the level of secondary structure. The spectra for the K32M: 1+4 does reveal that there
are some differences in the secondary structural content between this mutant and Quad3,
particularly at pH 8. Since this mutant possesses 2 K32M mutations at that correspond to
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Figure 5. Fapp curves generated from pH titration experiments with Quad3 in the
presence of various concentrations of NaCl to examine salt effects on the “closed” to
“open” forms. Titration experiments were performed in the presence of
MTH ({,
), MTH containing 0.2M NaCl ( ,
), MTH containing 0.5M NaCl
( ,
), and MTH containing 0.75M NaCl (V,
).
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Table 1. Salt effects on the pKa of Quad3.
pH titration experiments were carried out in
MTH buffer over the pH ranges of 8 to 4, in
the presence of NaCl to adjust the ionic
strength.
Salt Concentration

pKa value

0

5.9 ± 0.01

0.25

5.95 ± 0.01

0.5

5.7 ± 0.01

0.75

5.6 ± 0.02
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Figure 6. Circular dichroism spectra for Quad3 and each of the K32M double mutants at
pH 8 and pH 5. (A) Panel A depicts the spectra generated at pH 8 for Quad3 (
),
K32M: 1+2 ( ), K32M: 1+3 ( ), and K32M: 1+4 ( ). (B) Panel B illustrates the
spectra generated for these proteins at pH 5.
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the dimer-dimer interface in wt R67 DHFR, some perturbation may exist. This particular
construct was however generated to minimize any effects of the substitution by mutating
gene copies 2 and 3, as opposed to 1 and 4. Gene copies 2 and 3 correspond to domains
in the protein that are tethered by a linker sequence. Thus, the tether is expected to
reduce changes in the “closed” vs. “open” forms of Quad3 with respect to this mutant.
Steady-StateKinetics with K32M Double Mutants
K32M: 1+2
This R67 DHFR mutant protein contains K32M mutations in domains 1 and 2 and
has wild-type K32 residues in domains 3 and 4 (Figures 3 and 4). This results in one
wild-type site for binding either cofactor or substrate in each half of the pore. The kinetic
data for the K32M: 1+2 mutant indicate that NADPH binding is 4 fold weaker, DHF
binding is 2 fold weaker, and kcat is decreased 4 fold (Table 2).
In order to evaluate the number of ionic interactions with each ligand as well as
the involvement of K32 in these interactions, salt effects on this mutant were analyzed.
These studies were performed in TE buffer, pH 7 in the presence of various
concentrations of NaCl to adjust the ionic strength. Both Km (NADPH) and Km (DHF) increase
with increasing ionic strength (Tables 3 and 4). A salt concentration dependence of these
parameters reflects ionic interactions exist between this mutant and substrate as well as
with cofactor. However, salt has only a small effect on kcat (Figure 7).
K32M: 1+4
Steady-state kinetics were also performed with the K32M: 1+4 mutant, which
possesses mutations in gene copies 2 and 3, and reveal that this mutant binds NADPH
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Table 2. Steady-state kinetic values for the K32M asymmetric double mutants in
MTH buffer, pH 7 at 30°C. Data were fit using the non-linear SAS program
describing the bi-substrate kinetics of the R67 DHFR reaction.
Km (DHF)
(µM)
6.7 ± 0.4

kcat (s-1)

Quad 3a

Km (NADPH)
(µM)
4.4 ± 0.4

K32M 1+2

17.1 ± 0.09

14.4 ± 0.06

0.2 ± 0.01

K32M 1+3

≥ 160

≥ 330

≥ 3.6

K32M 1+4

5.4 ± 0.2

10.5 ± 0.3

0.1 ± 0.01

Quad Species

a

0.8 ± 0.02

from (1).
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Table 3. Steady-state kinetic values for the K32M: 1+2 mutant in TE buffer
pH 7 with various concentrations of NaCl added to adjust the ionic strength.
Km (NADPH)
Salt
Concentration (µM)
(Ionic
Strength)
0.03
8 ± 0.3
(µ=0.05)

Km (DHF)
(µM)

kcat (s-1)

17 ± 0.8

0.33 ± 0.01

0.05
(µ=0.07)

11.4 ± 0.5

14.6 ± 0.5

0.30 ± 0.02

0.08
(µ=0.1)

11.2 ± 3.0

23.2 ± 7.0

0.31 ± 0.02

0.1
(µ=0.12)

15.9 ± 0.5

34.2 ± 0.5

0.33 ± 0.02

0.132
(µ=0.15)

30.1 ± 1.8

51.1 ± 2.6

0.4 ± 0.04

0.132
(µ=0.15)

31.1 ± 2.5

27.7 ± 1.5

0.37 ± 0.02

0.16
(µ=0.18)

30.6 ± 1.1

60.6 ± 3.1

0.4 ± 0.01

0.2
(µ=0.22)

60.8 ± 2.9

63.6 ± 2.4

0.41 ± 0.03

0.2
(µ=0.22)

45 ± 1.9

43 ± 1.7

0.43 ± 0.01
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Table 4. Slopes of log-log plots of various kinetic parameters vs. ionic strength
for the K32M: 1+2 and K32M: 1+4 mutants compared to wt R67 DHFR.
DHFR
Species

Slope
kcat/Km

Slope
kcat/Km

Slope kcat Slope
Km (NADPH)

Slope
Km (DHF)

(NADPH)

(DHF)

wt R67
DHFR

0.6 ± 0.09

0.9 ± 0.03

0.8 ± 0.03

1.5 ± 0.1

1.8 ± 0.2

K32M: 1+2

1.1 ± 0.13

0.72 ± 0.16

0.2 ± 0.05

1.3 ± 0.02

0.9 ± 0.02

K32M: 1+4

1.1 ± 0.2

1.2 ± 0.2

0.2 ± 0.02

1.3 ± 0.06

1.3 ± 0.2
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Figure 7. Log-log plots of each kinetic parameter vs. ionic strength for the
K32M: 1+2 mutant. There is a linear correlation between each parameter and
ionic strength. Steady-state kinetics were performed in TE buffer pH 7 at
30°C.
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with the same affinity as Quad3 while there is a 1.6 fold decrease in the affinity
for DHF. The Km (NADPH) is 5.4 ± 0.2 µM and the Km (DHF) is 10.5 ± 0.3 µM
compared to 4.4 ± 0.4 µM and 6.7 ± 0.4 µM for Quad3 (Table 2). However, the
kcat is decreased 8-fold by this mutation, 0.1 ± 0.01 s-1 compared to 0.8 ± 0.02 s-1
for Quad 3.
The salt concentration dependence of the Km values for cofactor and substrate
were evaluated for this mutant (Figure 8). Both Km (NADPH) and Km (DHF) are salt sensitive
indicating ionic interactions are present in this mutant (Tables 4 and 5). However, kcat is
only minimally affected by salt concentration.
K32M: 1+3
The K32M: 1+3 mutant protein possesses mutations in gene copies 2 and 4,
which are equivalent to domains 1 and 3 in Quad3. This mutation results in one half of
the pore containing two K32M mutations, leaving the other half of the pore wild type
(Figures 3 and 4). The Km (NADPH) for this mutant is ≥160 µΜ and the Km (DHF) is ≥ 330

µM compared to 4.4 ± 0.4 µM and 6.7 ± 0.4 µM, respectively for Quad3 (Table 2 and
Figure 9) (1). The kcat is increased ≥ 3.6 fold compared to Quad3.
Due to the extreme elevation in the Km values for both substrate and cofactor
resulting from this mutational configuration, the salt sensitivity of these kinetic
parameters were not attainable. Changing assay wavelengths from 340 nm to 360 nm
allows higher concentrations of DHF and NADPH to be used for kinetic analysis, since
360 nm lies slightly off the peak absorbance for these ligands. Therefore, the total
absorbance is better maintained within the limits of the spectrophotometer. Even this
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Figure 8. Log-log plots of the kinetic parameters for the K32M: 1+4 mutant vs. ionic
strength. Kinetic experiments were performed at 30° C in TE buffer, pH 7 with various
concentrations of NaCl to adjust the ionic strength.
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Table 5. Kinetic values for salt effects on the K32M: 1+4 mutant in the presence of
TE, pH 7 with NaCl added to adjust the ionic strength.
Salt Concentration
(Ionic Strength)

Km (NADPH)
(µM)

Km (DHF)
(µM)

kcat
(s-1)

0.08
(µ=0.1)

7.2 ± 0.2

12.6 ± 0.4

0.19 ± 0.01

0.13
(µ=0.15)

12.2 ± 0.5

27.7 ± 1.0

0.30 ± 0.01

0.2
(µ=0.18)

22.4 ± 0.08

39.9 ± 1.4

0.22 ± 0.01

0.23
(µ=0.25)

23.7 ± 1.1

39.1 ± 2.0

0.22 ± 0.01

0.28
(µ=0.3)

28.7 ± 1.6

48.8 ± 4.0

0.19 ± 0.01

0.28
(µ=0.3)

32.7 ± 1.7

76.6 ± 4.9

0.32 ± 0.01
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(µM)
(µM)

Figure 9. Illustration of SAS fit to K32M: 1+3 kinetic data in MTH buffer, pH 7 at
30°C. From the plot, it is apparent that there is not a plateau in the rate of the reaction
with increasing DHF concentration. A plateau is also absent when the rate of the reaction
is plotted vs. NADPH concentration. The Km (DHF) values are sufficiently high that they
cannot be accurately obtained. To attempt to bracket Km (DHF), concentrations of DHF
used for these studies were extremely high. Thus, NADPH concentrations had to be kept
to a minimum to monitor the reaction within the limits of the spectrophotometer.
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approach however, was not sufficient to bracket Km (DHF). Steady-state kinetics were also
attempted in TE buffer, pH 7 with 0.01M NaCl (µ = 0.03). This buffer was used since it
has a lower ionic strength than MTH buffer. Unfortunately, the Km (DHF) was still
unattainable, as Km (DHF) was ≥ 490 µM, Km (NADPH) was ≥ 60µM, and kcat was

≥ 4.9 s-1.
Discussion
Previous docking, NMR, and salt effect studies have been used to create a model
for both NADPH and DHF binding in the pore of R67 DHFR (3, 19, 20). These studies
support a model where ionic contacts are involved in NADPH and DHF binding in the
ground state as well as the transition state. However, the salt effect studies on kcat and
kcat/Km (NADPH) and kcat/Km (DHF) in wt R67 DHFR indicate that the loss of an ionic
interaction facilitates formation of the transition state and thus product formation (8).
While salt effects were used in the previous study with wt and K33M DHFRs to ascertain
the number of ionic contacts involved in ligand binding and catalysis (8), a more
qualitative approach is being used in the current study to evaluate the importance of ionic
interactions. This approach has been adopted due mainly to the complication of
deciphering the exact number of ionic interactions from the salt effect data on the K32M
double mutants compared to those of wt and K33M DHFRs. However, the overall goal
of this project remains, to identify residue(s) involved in the ionic contacts with cofactor
and substrate to generate a model for the involvement of ionic interactions in the
mechanism for R67 DHFR.
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DHF Binding
Insight into the role of K32 in interactions with the substrate have progressed
through studies with the K32M: 1+3 mutant. The large effects on DHF binding in this
mutant reveal that K32 residues must be involved in interactions with substrate. While
salt effects were not directly examined for the K32M: 1+3 mutant, these contact(s) are
most likely ionic in nature. This hypothesis arises from several pieces of data. First, wt
R67 DHFR reveals that Km (DHF) is salt sensitive (8). In addition, a salt sensitivity for
folate binding (similar to DHF with the exception of a double bond between C7and C8)
has been directly monitored in the ternary complex of R67 DHFR•NADPH•folate using
ITC (8).
An increase in kcat is observed in the presence of increasing salt for wt R67 DHFR
and appears to arise in the K32M: 1+3 mutant as well, as kcat is ≥ 4.5-fold higher than that
of Quad3. Thus, this mutant which has lost any potential for an ionic contact with DHF
due to the substitution of both K32 residues in one half pore, mimics the effects of salt on
kcat for wt R67 DHFR. These data suggest that the loss of an ionic interaction(s) with
DHF facilitates formation of the transition state.
A general model for DHF binding in R67 DHFR can be generated using the
information from the K32M double mutant series as well as previous docking, NMR,
ITC, and salt effect studies (3, 4, 8). Once the R67 DHFR•NADPH complex has been
formed, DHF binds in the active site. The PABA-glu tail of DHF may form an ionic
interaction(s) with K32 in either subunit comprising the same half pore (Figure 10). This
could allow for a favorable enthalpy for binding due to the formation of direct contacts as
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Figure 10. Multiple conformations of the PABA-glu tail of folate predicted from
docking studies (3). A representation of the active site pore of R67 DHFR is illustrated
by the sphere cluster, with the position of K32 residues in the active site pore indicated in
red. The NADPH position in the active site is predicted by docking studies and is
depicted in green. Top scoring folate conformers from docking studies are illustrated in
yellow. While the position of the pteridine ring of folate is similar in these docked
conformers, the para-amino benzoic acid tail (PABA-glu) is predicted to be in multiple
orientations. Folate and DHF both possess the PABA-glu tail. Thus, DHF binding in the
active site may utilize multiple conformations of the tail to participate in contacts with
K32 residues in one half of the pore.
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well as reduce the entropic penalty by allowing movement with respect to the tail of
DHF. One way for this type of binding to be achieved is through water mediated ionic
interactions. Thus each K32 residue in one half pore may be solvated and thus indirectly
interact with the α and/or γ carboxylate groups on the tail of DHF. Thus, the tail of DHF
is likely bound in a manner that is "balanced". This describes ground state binding with
respect to DHF. On the other hand, when the glutamate tail of DHF is "pushed" or
"pulled" to the binding extremes in the K32M: 1+2 and K32M: 1+4 double mutants, the
catalytic rate suffers.
NADPH Binding
We have previously interpreted salt effects on wt R67 DHFR to indicate 2 ionic
interactions are involved in binding of NADPH in the ground state, while one ionic
interaction is lost to form the transition state. The effects of asymmetric K32M mutants
have been studied to examine more closely the role of K32 in ionic interaction(s) with
NADPH. The K32M: 1+2 mutant possesses one mutation in each half pore. The result
of this mutation is to decrease the salt effect on kcat while both Km (NADPH) and Km (DHF)
exhibit a salt effect. This behavior is also seen in the K32M: 1+4 mutant which also
possesses a single mutation in each half pore; however, in this mutant, both mutations are
at the same interface. The Km (NADPH) for the K32M: 1+2 mutant is approximately 3-fold
weaker than seen in Quad3. On the other hand, the Km (NADPH) for K32M: 1+4 mutant
possesses a Km (NADPH) that is approximately the same as that of Quad3. While the role of
K32 in ionic contacts with NADPH is less clear than with DHF, these data sheds some
light on NADPH binding in the active site pore of R67 DHFR. First, the apparent salt
sensitivity of Km (NADPH) and kcat/Km (NADPH) for these mutants, as well as a 50-fold effect
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on kcat/Km in the presence of NADH compared to NADPH for wt R67 DHFR, suggest
that at least one ionic interaction may occur between K32 and NADPH. Second, there
may be a slight preference for NADPH binding in the active site pore for the K32M: 1+2
mutant configuration as it displays a 3-fold decrease in affinity compared to the K32M:
1+4 mutant which displays a binding affinity similar to Quad3.
The kcat for both of these mutants is lower than that of Quad3. This could result
from the decrease in wt K32 residues available for binding NADPH or DHF in each half
pore. This may in turn effect ground state binding, leading to a decrease in the number
of possible binding modes available to reach the transition state and thereby reduce kcat.
In addition, only a small effect on the slope of kcat in the presence of salt is observed for
these mutants. If this small effect corresponds to the bottom of a titration curve, then
higher concentrations of salt may be required to observe an increase in kcat. Thus, the
range of salt concentration used for these experiments may not be sufficient to observe a
salt effect on kcat. This hypothesis can be examined by performing kinetics at higher salt
concentrations.
The K32M: 1+3 mutant possesses mutations in one half of the pore leaving the
other half of the pore containing two wild-type K32 residues (Figures 3 and 4).
According to the binding scheme for R67 DHFR (21), NADPH binding occurs first, so
we would predict that NADPH would preferentially bind in the wt half of the pore. In
this case, we would expect that Km (NADPH) is unaffected in this mutant, while DHF would
be forced to bind to the mutant half of the pore, resulting in a large effect on Km (DHF) if
K32 is indeed involved in ionic interaction(s) (direct or indirect) with DHF. This type of
pattern has been previously observed in the Y69F double mutant series (Stinnett,
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unpublished results). The results of the kinetics for this K32M: 1+3 mutant are therefore
surprising since the Km (NADPH) is affected as well as the Km (DHF). One possibility for this
result is a change in the order of binding. This seems unlikely since the affinity for
NADPH is at least 2 times greater than for DHF in this mutant. Another possibility is the
mutation results in a reduction of the positive electrostatic potential at the active site,
which concomitantly causes a decrease in the affinity for NADPH. This seems unlikely
as both of these mutations are on the same half of the pore with their sidechains pointing
in the same direction in the active site. This should cause the electrostatic potential to be
diminished on the face of the pore possessing the mutations. The electrostatic potential
on the face without mutations is predicted to remain unaffected; thereby the affinity for
NADPH is expected to be similar to that of the wild-type enzyme. A third, more likely
possibility, is that the Km (NADPH) is kinetic and does not reflect the true Kd (NADPH). This
can occur if rate constants other than enzyme-substrate are included in the Km (NADPH)(22).
This hypothesis still needs to be tested.
This research sheds light on the binding of NADPH in the active site of R67
DHFR and aids in the generation of models to describe the origin of the two ionic
contacts involved in NADPH binding. One possible model includes 2 K32 residues
involved in ionic contacts with the 2' phosphate and the pyrophosphate bridge of NADPH
and the α and γ carboxylate groups on the DHF tail. While there is a salt effect for both
NADPH and DHF binding in the K32 double mutants, the exact number of interactions
cannot be interpreted confidently. However comparison of the slopes for Km (NADPH), kcat,
and kcat/Km (NADPH) vs. ionic strength for the K32M double mutants and wt and K33M
DHFRs, reveal that the largest effects are upon the slopes for kcat vs. ionic strength.
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Thus, the absence of a significant difference in the Km (NADPH) for the K32M: 1+2 and
K32M: 1+4 mutants as well as the negligible differences in the slopes of the Km (NADPH)
vs. ionic strength plots for these mutants refutes a model involving 2 K32 residues
interacting with both charged moieties on NADPH. A second model includes one K32
residue and a cluster of positively charged residues on the surface of R67 DHFR. In this
model, there is a direct ionic contact between K32 and NADPH and an indirect longrange ionic interaction contributed by a charged cluster located on the surface of R67
DHFR. Interestingly, R67 DHFR possesses a cluster of charged residues on its surface,
which are conserved. This includes residues R31, E60, R29 and E75. Long-range
electrostatic effects have been implicated in ligand binding and catalysis through their
demonstrated importance in protein stability, protein-protein interactions, and effects on
pKa values of active site residues (23). A third model involves two K32 residues, one in
each half of the pore making at least one ionic contact with NADPH and at least one
ionic contact with DHF in the ground state. To reach the transition state, one or more of
these interactions are broken, thus facilitating catalysis.
Summary and Conclusions
Data from the K32M asymmetric mutants reveal that R67 DHFR may utilize
symmetry to achieve binding in the ground state as well as facilitate catalysis. Symmetry
of the active site may thus provide equivalent binding sites. Thus, removing two K32
residues from one half pore, as in the K32M: 1+3 mutant, results in a large penalty in
ground state binding. However, this is partially compensated for by an increase in kcat.
The value of 3.6 s-1 may reflect an upper limit for kcat that would correspond to a salt
independent value. However, since the Glu tail of DHF still possesses a charge, this
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condition does not quite mimic the salt conditions. Therefore, the intrinsic kcat could be
different and perhaps higher. This data suggests that ionic contacts, while important for
ground state binding, must be broken to facilitate formation of the transition state.
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Part IV: Contribution of Ionic Interactions to the Catalytic Mechanism
of R67 Dihydrofolate Reductase
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Introduction
R67 dihydrofolate reductase (DHFR) is a homotetrameric enzyme that possesses
222 symmetry in the active site pore (1). NMR and docking studies predict that ionic
interactions are involved in cofactor and substrate binding (2, 3). Yet, only one charged
residue occurs in each monomer which projects into the active site and thus possesses the
potential to participate in ionic contacts, K32. The only other charged residue near the
active site is K33, yet its side chain points away from the active site out into solvent (1).
Both K32 and K33 have also been predicted by DELPHI, a finite Poisson-Boltzmann
difference solver, to generate a positive electrostatic potential at the active site pore (3,
4). This positive potential may be important for attracting the negatively charged ligands,
NADPH and DHF, to the pore of R67 DHFR thereby facilitating catalysis.
Based on these preliminary findings, the importance of ionic interactions in R67
DHFR was experimentally tested. The goal of this research was to aid in the
understanding of the role of ionic interactions in the ground and transition state binding.
This final chapter summarizes these findings as well as provides a general model for the
overall contribution of ionic interactions to binding and catalysis in the R67 DHFR
reaction mechanism.
Proposed Ionic Interactions with NADPH and DHF
NADPH and DHF both possess net negative charges. The net negative charge of
NADPH is –3, which arises from the oxygen atoms of the pyrophosphate bridge and the
oxygen atoms of the 2’phosphate off the hydroxyl of the ribose attached to the adenine
ring. DHF possesses a net charge of –2 resulting from negatively charged α and γ
carboxylate groups on the glutamate residue at the end of the para-aminobenzoic acid tail
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(PABA-glu). In order to investigate the prediction that the negatively charges moieties of
NADPH and DHF are important for binding to R67 DHFR, a combination of
mutagenesis, kinetics, fluorescence quenching, and isothermal titration calorimetry
approaches have been performed.
Number of Ionic Interactions Involved in Ligand Binding
Salt sensitivities were previously recorded for kcat/Km (NADPH), kcat/Km (DHF), and kcat
for both wt and K33M DHFRs. While these data support a role for ionic contacts in
ligand binding as well as in catalysis, the number of ionic interactions involved in each of
these processes was still an open question. To evaluate this, slopes of log-log plots of Kd,
Km, kcat, and kcat/Km vs. ionic strength were measured (5). This approach was first
reported in 1976 by Record et al., using DNA binding to proteins (6). More recently, this
has been described by Park and Raines using Ribonuclease A binding to DNA (7). Salt
effects on Kd1 (NADPH) were investigated using both ITC and fluorescence quenching.
Slopes of log-log plots of Kd1 (NADPH) vs. ionic strength were 2. However, Kd (DHF) vs.
ionic strength could not be obtained using these techniques. Additionally, slopes of the
log-log plots of Km (DHF) vs. ionic strength and Km (NADPH) were 2 (5). While we were
skeptical of relying on the slopes of the Km vs. ionic strength plots as Kms can reflect rate
constants other than the formation of the enzyme-substrate complex (8), agreement
between the slopes of the log-log plots for Kd (NADPH) and Km (NADPH) led us to consider the
simple interpretation that two ionic interactions were involved in NADPH binding in the
2NADPH complex as well as the ternary E•NADPH•DHF complex. In retrospect, the
salt sensitivity of Kd (NADPH) monitors the formation of the binary complex and does not
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necessarily reflect the salt sensitivity of the productive ternary complex. Due to this
complication, we will consider what possible models remain to explain the data.
Salt effects on folate in the ternary E•NADPH•folate complex were investigated
(folate is similar in structure to DHF with the exception of a double bond between C7 and
C8). The data reveal that folate binding in the ternary complex is salt sensitive. This
observed salt sensitivity indicates that ionic contact(s) are directly involved in the ground
state binding of DHF.
Salt sensitivity of the parameters kcat, kcat/Km (NADPH), and kcat/Km (DHF) for wt R67
DHFR provides information concerning the role of ionic contacts in formation of the
transition state as well as catalysis. Specifically, the observed increase in kcat with
increasing salt concentration reflects that catalysis is facilitated by the loss of an ionic
contact(s). This behavior is also observed in the presence of the alternate cofactor
NADH, which lacks the 2’phosphate of NADPH. However, there is a 50-fold reduction
in kcat/Km (NADH) compared to kcat/Km (NADPH) indicating the 2’phosphate is important for
formation of the transition state. This also suggests that the 2’phosphate of NADPH is
important for ground state binding of NADPH.
These data support the hypothesis that at least one ionic contact is involved in the
ground state binding of each ligand. The identity of the interaction monitored by kcat
remains unidentified by these studies, although we proposed this was an interaction with
the pyrophosphate bridge of the cofactor.
Which Residue(s) in R67 DHFR are Involved in Ionic Contacts?
To directly examine the hypothesis that K32 is involved in ionic contacts with
substrate and cofactor as well as formation of the transition state, K32 was substituted by
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methionine in the R67 DHFR homotetramer using PCR mutagenesis. Mutagenesis of
one residue in the homotetramer results in modification at four related sites. The
outcome of this substitution resulted in the formation of an inactive dimer. Thus, a direct
approach to studying the role of K32 was not possible. To rule out the possibility of the
involvement of K33 in these interactions, the only other charged residue near the active
site, K33 was substituted with the non-polar reside methionine to eliminate its ability to
form ionic contacts. Salt effects on both K33M and wt R67 DHFRs were then pursued.
The similarity of the kinetic behavior of the K33M mutant to that of wt R67 DHFR
indicates K33 does not participate in ionic contacts with the ligands.
To directly address the role of K32 in ionic interactions in R67 DHFR, a fourgene copy construct of R67 DHFR that was linked in frame was utilized. The resulting
protein from this construct has a molecular weight equal to four times that of a monomer
of wt R67 DHFR, where each domain of this protein is equivalent to a monomer in the
R67 DHFR homotetramer. This protein is called Quad3 (9). Asymmetric K32 mutations
were generated in this system.
The K32 asymmetric double mutants constructed include K32M: 1+2, K32M:
1+3, and K32M: 1+4, where domains containing mutations are indicated numerically.
Thus, each construct contains the same number of mutations but differs only in which
domains possess the mutations. K32M: 1+2 and K32M: 1+4 both possess one mutation
in each half pore. However, mutations in K32M: 1+2 occur in domains located across
the pore from one another while mutations in K32M: 1+4 occur in adjacent domains that
lie at the same interface. Both of these mutants have minimal effects on Km (NADPH) and
Km (DHF) compared to Quad3, 4-fold and 1.2-fold, respectively and 2-fold and 1.6-fold,
135

respectively. The catalytic rate constant, kcat, however is decreased 4-fold and 8-fold,
respectively by these mutations. Additionally, salt effects on these mutants reveal that
while Km (NADPH), Km (DHF), kcat/Km (NADPH), and kcat/Km (DHF) are salt sensitive; kcat is
mostly insensitive to ionic strength over the range of 0.03 –0.3µ. Log-log plots of each
kinetic parameter vs. ionic strength were generated. When these plots are compared to
those for wt R67 DHFR, they reveal that the most significant change in slope occurs with
respect to kcat. This reduction in kcat compared to Quad3, the minimal effect of salt on
this parameter, as well as the significant change in slope for the kcat vs. ionic strength
plots for these mutants compared to wt R67 DHFR, indicates K32 is involved in
catalysis. The observed decrease in kcat with these mutants can be explained if these
mutants effect ground state binding by limiting the options available for an ionic contact
between a wt K32 and NADPH in one half pore and a wt K32 residue and DHF in the
other half pore. Concomitantly, this would decrease the number of possible binding
modes available to reach the transition state and thereby reduce kcat.
The K32M: 1+3 mutant contains two mutated K32 residues in one half of the
active site pore of R67 DHFR, while the other half of the pore still contains two wildtype K32 residues. From the binding scheme devised by Bradrick et al., (10) NADPH
binding occurs first, followed by DHF. Thus, NADPH is expected to bind to the wildtype half pore of this mutant, forcing DHF to bind to the mutant half pore. However,
kinetic analysis of this mutant indicates there are large effects on Km (NADPH) and Km (DHF),

≥ 36-fold and ≥ 49-fold, respectively. This unexpected elevation in Km (NADPH) may not
accurately reflect the true Kd of binding and may include other rate constants (8). This
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hypothesis can be experimentally assessed using fluorescence quenching to monitor the
Kd for NADPH.
The kcat for the K32M: 1+3 mutant is increased ≥ 4.5-fold compared to Quad3.
An increase in kcat can be explained if the effects of this mutant are compared to the salt
effects on wt R67 DHFR. In wt R67 DHFR, there is an increase in kcat with increasing
salt concentration suggesting that formation of the transition state is facilitated by the loss
of an ionic interaction. Similarly, in the K32M: 1+3 mutant, two K32 residues in one
half of the active site pore are substituted by methionine. Since DHF binding occurs after
NADPH, DHF is forced to bind in the mutant half pore in which there is no possibility
for ionic contact(s) with K32 residues. While this has large deleterious effects on the
ground state binding of DHF, it is compensated for by an increase in kcat for this mutant.
This observed increase in kcat may be a direct result of the elimination of ionic contact(s)
in this mutant. Thus, while ionic interactions are important for ground state binding, their
loss concurrently aids in the formation of the transition state.
The K32M: 1+3 mutant provides insight into the role of K32 in DHF binding.
The significant increase in Km (DHF) when both K32 residues in one of the half pore are
mutated to methionine indicates that K32 has an ionic interaction(s) with DHF. Yet,
NMR, crystallography, and docking data suggest that the tail of DHF is mobile. A
possible scenario consistent with this data may arise from the formation of a watermediated interaction(s) between the two K32 residues in the same half pore and some
combination of the α and γ-carboxylate groups of DHF (Figure 1). This type of
interaction is referred to in the literature as a solvent separated ion pair. Solvent
separated ion pairs are clearly seen in small molecules, particularly in crystals, but have
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A

B

Figure 1. Representation of the top 23 scoring folate conformers predicted by DOCK in
the active site pore of R67 DHFR. Green indicates carbon, blue illustrates nitrogen, red
depicts oxygen, and white indicates hydrogen atoms. Symmetry related K32 residues are
illustrated in yellow (3). (A). The top scoring folate conformers in the active site pore
illustrate various potential dockings where one of the carboxylates in the glu tail of folate
is near K32 in the C subunit (top) while another set of docked folate conformers place the
glu tail near K32 in the A subunit. In each conformer, a solvent separated ion pair could
occur with the symmetry related K32 residue. (B). A 90 rotation of the image in panel A
indicates that folate conformers were predicted to fall into two main groups. The
conformers within both groups possess the ability to interact with a K32 residue in the
same half pore. The wide range of conformers predicted by DOCK is consistent with
NMR and crystallographic studies that indicate the DHF tail is mobile in solution. This
suggests that the tail may occupy various positions within the active site of R67 DHFR
and thus may participate in a direct but weak ionic interaction with K32 as well as a
water mediated interaction(s).
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also been proposed to occur in DNA binding proteins and catechol O-methyltranferase
(11-14). In addition, recent studies of salt effects on the pKa values of histidines in
staphylococcal nuclease show clear perturbations (15). From mutational studies as well
as modified Poisson-Boltzmann calculations, Lee et al. conclude these perturbations arise
from nearby charge clusters. Interestingly, a plot of the relationship between interaction
energy and distance between charged pairs as a function of ionic strength indicates
charges separated by ~ 5 Å gave an average interaction energy of 0.6 kcal/mol in 0.01 M
KCl. Thus, charge-charge interactions can exist at greater than van der Waals contact
distances, arising from electric fields that display a 1/r distance dependence. If water
separates the interacting pairs, a diminished interaction energy can be expected, although
this may be partially countered by not needing to pay a desolvation penalty (16). As salt
concentration increases to 0.1M KCl, the average interaction energy of charge-charge
pairs separated by ~ 5 Å decreases to 0.4 kca1/mol (15). In R67 DHFR, the symmetry of
the half pore may allow the glutamate tail of DHF to be bound in a balanced position,
halfway between two K32 residues to facilitate an interaction with either the α and/or γ
carboxylates. Any diminishing of the electric fields established by the charges by
increasing salt concentrations may then allow movement of DHF further into the pore so
that the distance between the C6 of DHF and the C4 of NADPH is reduced. This
movement would allow closer contact between the hydride acceptor and donor positions.
From docking studies, the distance is predicted to be ~ 4.5 Å, however a distance of
2.6 Å is predicted to actually achieve hydride transfer (17, 18).
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Based on the results of the K32M double mutants, the following conclusions can
be drawn concerning the role of K32 in binding and catalysis. First, K32 forms an ionic
interaction(s) with DHF in the ground state (potentially mediated by water) as observed
from the significant increase in the Km (DHF) for the K32M: 1+3 mutant. Second, K32 is
involved in catalysis as the removal of one K32 in each half pore, as in the case of the
K32M: 1+2 and K32M: 1+4 mutants, results in a significant decrease in kcat.
Alternatively, loss of both K32s in one half-pore (K32M: 1+3) results in a significant
increase in kcat.
Insight into the Role of K32 in R67 DHFR: Comparison of Y69F and K32M
Asymmetric Double Mutants
Asymmetric mutants were originally generated to assess the importance of
individual residues in ligand binding as well as to engineer specificity. So far, the effects
of the Q67H (9), Y69F (Lori Stinnett, unpublished) and K32M asymmetric double
mutant series have been examined. Comparison of these double mutants lends insight
into the role of symmetry in the active site pore of R67 DHFR. Kinetic data from those
mutants that lie away for the 222 center of symmetry indicate that mutations in domains 1
and 2 (Y69F: 1+2 and K32M: 1+2) or in domains 1 and 4 (Y69F: 1+4 and K32M: 1+4),
i.e. one mutation in each half pore, result in minimal effects on binding of NADPH and
DHF. This is reflected by small increases in Km values for both of these ligands
(Table 1). Therefore, the minimal effect on binding in these mutants suggests that only
one of each of these residues is necessary for binding cofactor and substrate.
Differences between the Y69F and K32M series of asymmetric double mutants
arise when mutational effects on kcat are studied. Y69F: 1+2 and Y69F: 1+4 result in
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Table 1. Kinetic characterization of Quad3, K32M double
asymmetric mutants, and Y69F double asymmetric mutants in
MTH, pH 7 at 30°C.
Mutant

Km (NADPH)
(µM)

Km (DHF)
(µM)

kcat (s-1)

Quad3a

4.4 ± 0.4

6.7 ± 0.4

0.8 ± 0.02

K32M: 1+2

17.1 ± 0.1

6.7 ± 0.1

0.2 ± 0.01

K32M: 1+3

≥ 160

≥ 330

≥ 3.6

K32M: 1+4
Y69F: 1+2b

5.4 ± 0.2
15.1 ± 0.6

10.5 ± 0.3
17.7 ± 0.8

0.1 ± 0.01
1.1 ± 0.03

Y69F: 1+3b

2.9 ± 0.3

20.3 ± 1.5

0.66 ± 0.03

Y69F: 1+4b

13.1 ± 0.6

25.2 ± 1.6

1.7 ± 0.01

a

(Ref 9)
(Lori Stinnett, published and unpublished results)

b
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minor increases in kcat, 1.4-fold and 2-fold effects, while K32M: 1+2 and K32M: 1+4
result in 4-fold and 8-fold decreases in kcat (Table 1). Thus, K32 plays a larger role in
catalysis than Y69. Further, the decrease in kcat as well as its lowered sensitivity to salt
concentration, for the K32M: 1+2 and K32M: 1 +4 mutants as compared to wt R67
DHFR, illustrates these mutants may affect formation of the transition state. As
mentioned previously, this situation could arise due to these mutants possessing only one
K32 capable of participating in an ionic interaction in each half pore. Thus, these
mutants may impose a constraint on formation of the ground state as the ligands are
forced to interact with the remaining K32 residue in each half pore. Concurrently, the
number of possible binding modes is reduced. As a result, the number of species
available to form the transition state would decrease giving rise to fewer available species
to participate in catalysis. Thus, kcat would be lower than that of Quad3. This is
consistent with the observed decrease in kcat for the K32M: 1+2 and K32M: 1+4 mutants.
In contrast, the K32M: 1+3 mutant, which contains both mutations in one half pore,
results in a ≥ 36 fold elevation in Km (NADPH), a ≥ 49 fold elevation in Km (DHF), as well as a

≥ 4.5 fold increase in kcat compared to Quad3. The significant increase in Km (DHF) for this
mutant suggests that K32 participates in an ionic contact(s) with DHF that appears
important for ground state binding. Alternatively, the higher kcat value observed for this
mutant, which lacks the ability to participate in ionic contacts with DHF compared to
Quad3, indicates that these ionic contacts impede formation of the transition state in wt
R67 DHFR.
Together, these data suggest that R67 DHFR uses symmetry to facilitate catalysis
by providing equivalent binding sites in the active site pore. Furthermore, breaking the
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symmetry only leads to a scenario that partially mimics the salt effect when both K32
residues are removed from one half of the pore. This suggests R67 DHFR uses its
symmetry to produce a binding mode for DHF that is balanced between the K32 residues.
When the glutamate tail of DHF is “pushed” or “pulled” to the two binding extremes in
the K32M: 1+2 and K32M: 1+4 double mutants, the catalytic rate suffers.
General Models for K32’s Participation in Ionic Interactions with NADPH and DHF
Several models can be generated to describe a role for K32 in ionic interactions in
wt R67 DHFR. (1) As proposed in part II, two K32 residues may participate in ionic
interactions with NADPH. This model is refuted by the results from part III, where
effects of a single K32M mutation in each half pore, as seen in the K32M: 1+2 and
K32M: 1+4 mutants, are minimal. In addition, there is not a significant change in the
slopes of log-log plots of kcat/Km (NADPH) vs. ionic strength for these mutants compared to
wt R67 DHFR. (2) One K32 residue and a cluster of charged residues on the surface of
R67 DHFR may participate in ionic interactions with cofactor and substrate.
Electrostatic potential predictions by the computational algorithm DELPHI, a finite
Poisson-Boltzmann difference solver, predict that wt R67 DHFR possesses a positive
electrostatic potential at the active site pore (Figure 2). This electrostatic potential may
facilitate binding of NADPH and DHF. Generation of the asymmetric K32M double
mutants is predicted to reduce the positive electrostatic potential at the active site,
particularly in the case of the K32M: 1+3 mutant, which possesses 2 mutations in the
same half pore (Figure 2). Additionally, the surface of R67 DHFR possesses a group of
charged residues that are conserved including R31, E75, R29, and E60. This charged
cluster might also play a role in cofactor and substrate binding. The importance of
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C

D

Figure 2. Electrostatic potential predictions of K32M asymmetric double mutants
generated using DELPHI, a finite Poisson-Boltzmann difference solver (3). Blue depicts
areas of positive electrostatic potential, red illustrates regions of negative electrostatic
potential, and white depicts areas of neutral potential. (A). The predicted electrostatic
potential for wt R67 DHFR indicates the active site pore possesses a positive electrostatic
potential generated mostly by symmetry related K32 residues. (B) The electrostatic
potential prediction for the K32M: 1+2 mutant indicates that substituting 2 K32 residues
with methionine at opposite ends of the pore (diagonally) reduces the positive
electrostatic potential at each end. (C). The electrostatic potential prediction for the
K32M: 1+4 mutant is quite similar to that from panel B, as substituting 2 K32 residues,
each at opposite ends of the pore, reduces the positive electrostatic potential at each end.
(D). The K32M: 1+3 mutant possesses a diminished positive electrostatic potential at the
active site pore due to the substitution of 2 K32 residues in the same half pore. Here the
potential at the end facing the viewer is greatly diminished.

144

clusters of charged residues in enzyme structure and function has been recently been
documented (19). (3) A third model includes at least one ionic contact between K32 and
NADPH as well as K32 and DHF in the ground state. However, to reach the transition
state, an ionic interaction is lost, most likely one between DHF and K32. This model
seems most likely from the data generated to date. The lack of significant effects on the
Km values for NADPH and DHF in the K32M asymmetric double mutants K32M: 1+2
and K32M: 1+4, the reduction in kcat for these mutants, a minimal salt effect on
kcat/Km (NADH), as well as a significant effect on DHF binding with the K32M: 1+3
mutant, support that there is at least one ionic interaction in the ground state with each
ligand. Additionally, support for the loss of an ionic interaction in the transition state
comes from the observed increase in kcat in the presence of increasing ionic strength for
the K32M: 1+3 mutant and wt R67 DHFR, the salt sensitivity of kcat/Km (NADPH) and
kcat/Km (DHF) for wt R67 DHFR, and the increase in kcat with increasing ionic strength in
the presence of the alternate cofactor NADH.
Model for Electrostatics in the Catalytic Mechanism of R67 DHFR
The data presented herein can be used to generate a general model describing the
total contribution of both the electrostatic potential and ionic interactions to the catalytic
mechanism of R67 DHFR. The positive electrostatic potential at the active site pore of
R67 DHFR attracts both NADPH and DHF. This facilitates binding of NADPH to the εamine group of K32 through the oxygen atoms of the 2’phosphate and/or the oxygen
atoms of the pyrophosphate bridge. DHF binding then occurs, facilitated by the
attraction of the positive electrostatic potential, and the α, γ, or some combination of
these carboxylate groups in the glutamate tail of DHF form an ionic contact(s), such as a
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water-mediated ionic contact, with K32 (Figure 1). This facilitates binding in an
orientation such that there is some overlap of the nicotinamide ring of NADPH and the
pteridine ring of DHF. Formation of the endo transition state is then achieved, which has
been suggested to be more favorable for R67 DHFR than the exo transition state (20). In
the endo transition state, the nicotinamide ring of NADPH and the pteridine ring of DHF
are stacked on one another resulting in the hydride on the C4 of the donating
nicotinamide ring being in close proximity to the accepting C6 of DHF. Hydride transfer,
the rate-limiting step, then occurs and the product, tetrahydrofolate, is released as well as
NADP+.
Summary and Conclusions
This research has provided insight into the role of K32 in the catalytic mechanism
of R67 DHFR. The overall approach used by R67 DHFR to facilitate catalysis involves a
symmetrical active site, which provides equivalent binding sites. Equivalent binding
sites appear to be especially crucial with respect to ionic interactions in the ground state.
Reducing the number of available sites for ionic contacts in the ground state results in a
decrease in kcat. This most likely arises from a reduction in the number of species able to
adopt the transition state. On the other hand, ionic interactions seem to impose a
constraint on formation of the transition state, as complete elimination of these
interactions at least with respect to DHF, results in an increase in kcat. Thus, there is a
fine balance between the symmetry of the active site pore, which is used to facilitate ionic
contacts for ground state binding, with the rate of product formation, which seems limited
by ionic contacts.
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